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Introduction: Falls are the leading cause of accidental injury in community dwelling older 
adults, often resulting in emergency room visits, hospitalization and early admission to long-term 
care. Studies have identified many risk factors for falls including increasing age, diagnosis of a 
chronic disease, poor vision, fear of falling, hazards in the home, alcohol and prescription 
medications. While studies have examined many risk factors associated with falls, there is 
limited information on whether prescription medications and alcohol are risk factors in 
community dwelling older adults.  
Purposes: The primary thesis objectives were to: i) conduct a literature review to synthesize the 
literature on whether alcohol and psychotropic, anti-depressant and anti-hypertensive 
medications are risk factors for falls in community dwelling older adults; ii) examine what health 
and social factors are associated with high-risk alcohol use in community-dwelling older adults 
in Canada,; and iii) examine whether alcohol and select medications are predictive of falls in 
community dwelling older adults.   
Methods: The first aspect of this thesis was to conduct a literature review on select medications 
(psychotropics, benzodiazepines or anti-psychotics, anti-depressants, and anti-hypertensives) and 
alcohol, both singly and in combination, on fall risk in community dwelling older adults using 
the following search terms: drug or medication, aged or elderly or older adult or senior, 
accidental falls or falls or falling, and alcohol or alcohol drinking. These search terms were 
entered into four databases (PubMed, EMBASE, CINAHL and SCOPUS). A total of 1,146 
articles were retrieved and screened for inclusion. Studies were included if 1) was a primary 
study; 2) included community dwelling persons aged 60 years and older; 3) included alcohol use 
as an independent variable; 4) included medications of interest; 5) falls were the primary 
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outcome variable; and 6) published in English. We excluded studies if they were: 1) review 
articles, conference proceedings, books, editorial, case studies or commentary; 2) if articles 
relied on qualitative data (interviews, focus groups); 3) if they were not in English; and 4) 
included institutionalized persons (e.g. living in LTC or hospital). 
Chapters 3 and 4 used data from the Canadian Injury Prevention Survey. The survey was 
distributed online to local, provincial and national organizations across Canada that cater to older 
adults (2016-2017) and collected information on demographics, perception of physical and 
mental health, fall history, alcohol use, use of psychotropic, anti-depressant and anti-
hypertensive medication use, smoking status, diagnosis of a chronic disease, physical activity, 
usual sleep quantity, likelihood of daytime sleepiness, and executive duties. While data was 
collected on community dwelling individuals 45 years and older, only data of those 65 years and 
older was examined in the present thesis (n=2,281).   
Chapter 3 examined alcohol use in community dwelling older adults (n=2,279). 
Participants reported the number of drinks they consumed per week and the number of days per 
week they consumed alcohol. The purpose of this chapter was to: 1) examine alcohol use in 
community dwelling older adults in Canada using current alcohol consumption guidelines; 2) 
develop and test new alcohol consumption guidelines to determine if they better differentiate 
drinking habits on health outcomes; and 3) determine risk factors of high-risk drinking. Low risk 
drinking was defined as 1-2 drinks per week for both males and females. Moderate drinking was 
defined as 3-9 drinks per week for males and 3-6 drinks for females. High risk drinking limits 
were defined as 10 drinks per week for males and 7 drinks per week for females. Using 
logistic regression, we examined demographic and health factors to predict low and high-risk 
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drinking. Multinomial regression was used to examine predictors of low, moderate and high-risk 
drinking. 
Chapter 4 examined the use of alcohol and select medications as risk factors for falls, 
both as independent predictors of falls, and together with alcohol (n=2,281). Participants 
reported prescription medication, alcohol use on a weekly basis and fall history. Medications 
examined included psychotropic (anxiolytics, anti-psychotics, hypnotics/sedatives), anti-
depressants (selective serotonin reuptake inhibitors (SSRI), serotonin antagonist reuptake 
inhibitors (SARI), serotonin-norepinephrine reuptake inhibitors (SNRI), tricyclic anti-
depressants, or other) and cardiovascular agents (diuretics, beta-blockers, angiotensin converting 
enzyme inhibitors, angiotensin II receptor antagonist, calcium channel blockers) on fall risk. 
Correlations were performed to determine health factors correlated with falls. Logistic regression 
determined medications predictive of falls.   
Results: The literature review (Chapter 2) found 29 observational studies that met the inclusion 
criteria after screening. Sample sizes ranged from 307 to 321,422. Twenty-six studies examined 
the effects of benzodiazepines, hypnotics/sedatives or anti-psychotic use on falls, and twenty 
found benzodiazepines, hypnotics/sedatives or anti-psychotics were predictive of falls. Thirteen 
studies examined anti-depressant use and falls; 10 studies found that anti-depressants are 
predictive of falls. Twelve studies examined anti-hypertensives as a risk factor for falls and four 
found anti-hypertensives were predictive of falls. Fifteen studies examined alcohol use and five 
found alcohol was a predictor of falls.  
Findings from Chapter 3 show that 70% of participants reported drinking at least once per 
week. Using the current Canadian alcohol consumption guidelines, 6.2% of older males and 
10.1% of older females were classified as high-risk drinkers. Moderate drinking was reported by 
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32.8% of males and 23.3% of females. When comparing current alcohol consumption guidelines 
to the new additional category (moderate drinking), there were no significant difference on 
health outcomes.   
Findings from Chapter 4 show that 33.4% of older adults had a fall in the previous two 
years. In fallers, 5.3% reported psychotropic use, 10.4% reported anti-depressant use, and 51.6% 
reported anti-hypertensive use. Anti-hypertensive medication and alcohol use was not associated 
with falls. As a group, psychotropic drug use was predictive of falls after controlling for potential 
confounding factors (p<0.05). Anti-depressant sub-classes SSRIs, SARIs and SNRIs were 
predictive of falls on their own and when controlling for sex (p<0.05).  
Conclusions 
 The literature review found benzodiazepines, hypnotics/sedatives, anti-psychotic and 
anti-depressants are predictive of falls in community dwelling older adults. Anti-hypertensive 
medication and alcohol use were not predictive of falls. Compared to females, males were more 
likely to be moderate drinkers, however, overall adding a moderate drinking category did not 
help differentiate health and social factors associated with alcohol consumption. Psychotropic 
drug use overall, as well as individual anti-depressant drug classes (i.e. SSRI, SNRI and SARI) 
were all predictive of falls after controlling for sex.  Anti-hypertensives and alcohol were not 
predictors of falls in community dwelling older adults based on the survey data. Findings of the 
literature review and survey data confirm psychotropic and anti-depressant use increase fall risk 
in community dwelling older adults. Clinicians should exercise caution when prescribing 
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Chapter 1: Introduction 
 
1.1 Thesis Overview 
 
Chapter 1 outlines the thesis objectives and a brief overview of the original University of 
Bordeaux project. Chapter 2 presents a literature review on the effects of select medications and 
alcohol on fall risk in older adults followed by Chapters 3 and 4 that are original research papers 
using data from the Canadian Injury Prevention Survey. Chapter 3 describes health and social 
factors associated with alcohol use and predictors of alcohol use in community dwelling older 
adults in Canada and Chapter 4 examines whether psychotropic, anti-depressants and anti-
hypertensives, both singly and in combination with alcohol, are associated and/or predictive of 
fall risk in community dwelling older adults. Lastly, Chapter 5 is a general discussion and 
summary of the main findings, implications for research and practice, followed by limitations, 
future directions and conclusions.  
1.2 Thesis Objectives   
 
The purpose of this thesis is to examine the role of alcohol and its interaction with 
various medications (i.e., psychotropic, anti-depressants, and anti-hypertensives) on fall risk in 
Canadian older adults (aged 65+). While studies have identified a plethora of risk factors for falls 
(e.g. age, chronic illness, previous falls, poor vision), a few studies have also suggested that 
select medications and alcohol may be risk factors (Milos et al. 2014; Sorock et al. 2006). 
However, there is a paucity of research in this area.  
Evidence suggests that older adults make up the highest percentage of prescription 
medication users in Canada (CIHI, 2012; PHAC, 2015). Prescription medication use including 
anti-psychotics, benzodiazepines such as sedatives/hypnotics and anti-depressants are identified 
as risk factors for falls in older adults (PHAC, 2014). Furthermore, some research also suggests 
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that anti-hypertensive medications also increase fall risk (Tinetti et al. 2014). The first aspect of 
this thesis aims to synthesize articles on anti-psychotic and benzodiazepines, anti-depressant and 
anti-hypertensive medications, as well as alcohol, that have examined fall risk in community 
dwelling older adults aged >60 years. The second aspect of this thesis is to examine alcohol use 
in older adults, develop new categories to determine if there was better differentiation between 
low, moderate and high-risk alcohol use in older adults on various health and social outcomes, 
and to compare current guidelines and new drinking categories for applicability to older adults. 
The third aspect of this thesis will examine the effects of medications, both individually and in 
combination with alcohol, on fall risk.   
1.3 Project Background 
 
This project was done in collaboration with Dr. Emmanuel Lagarde and the University of 
Bordeaux (France). Dr. Lagarde and his research team developed a survey on occupational 
health and transportation that was disseminated in a cohort of blue-collared workers in France 
over 25 years ago (called the GAZEL cohort study). Participants are followed every year, 
completing the same survey, which allowed for longitudinal assessment of how changes in health 
and occupation were related to changes in mobility patterns.  
Building from the GAZEL cohort study, their survey was adapted to a Canadian context 
prompting the addition and deletion of several items and questions. Questions concerning 
daytime sleepiness, physical activity, medication use (type, dosage per day), and day dreaming 
were added. In consultation with Dr. Lagarde, some questions that were not considered relevant 
or useful in the Gazel survey were removed (i.e. date of birth, marital status, number of children 
living in the home, assistance performing activities of daily living, assisting family members, 
weight and height, owners of pets, perceptions of balance, income, major life events, pain or 
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infections in past year, and hospitalization in past 12 months). After these revisions, the 
Canadian Survey consisted of 89 questions which aimed to examine how health and associated 
functional impairments, as well as behaviours (e.g. smoking, alcohol consumption, medication 



































Chapter 2: A Literature Review of Psychotropic Medications and Alcohol as 
Risk Factors for Falls in Community Dwelling Older adults  
 
Overview 
Background: Studies suggest that psychotropic medications, specifically anti-psychotics, 
benzodiazepines, anti-depressants, and anti-hypertensives are potential risk factors for falls, as is 
alcohol. However, these studies have consisted of older adults living in institutionalized care 
which include higher rates of medications and falls. There has been no appraisal of the literature 
on whether medications and alcohol are associated with falls in community dwelling older 
adults. The objective of this study is to review and synthesize peer-reviewed studies that 
examined select medications, both singularly and in combination with alcohol, on fall risk in 
community dwelling older adults.  
Methods: Four databases (PubMed, EMBASE, CINAHL and SCOPUS) and the grey literature 
(i.e. World Health Organization, Public Health Agency of Canada, Canadian Institute of Health 
Information) were searched using the following terms: benzodiazepines or anti-psychotics, anti-
depressants, anti-hypertensives: drug or medication, aged or elderly or older adult or senior, 
accidental falls or falls or falling, and alcohol. Studies were included if 1) was a primary study; 
2) included community dwelling persons aged 60 years and older; 3) included alcohol use as an 
independent variable; 4) included medications of interest; 5) falls were the primary outcome 
variable; and 6) published in English. Articles published until December 2017 were included. 
The search yielded 29 peer reviewed articles relevant to select medication and falls.  
Results: Twenty-nine studies were included in the review. Twenty-six studies examined the 
effects of benzodiazepine, hypnotic/sedative or anti-psychotic use on falls; twenty studies 
showed benzodiazepines, hypnotic/sedative or anti-psychotic use was predictive of falls in 
community dwelling older adults. Thirteen studies examined anti-depressant use and falls; ten 
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predicted falls. Twelve studies examined anti-hypertensive and falls; four were predictive of 
falls. Fifteen studies examined alcohol use and five found a significant association with falls. 
Only one study examined the concurrent use of alcohol with central nervous system (CNS) 
medications and falls but no association was found.   
Conclusion: The use of psychotropic and anti-depressant medications appears to be associated 
with falls in community dwelling older adults. Consequently, physicians and health care 
professionals should be cognizant of prescribing these medications to older adults who are 


































Select medications are suggested as risk factors for falls in older adults (WHO, 2007; 
PHAC, 2014). Four prior meta-analyses concluded that psychotropic medications including 
benzodiazepines/anti-psychotics and anti-depressants (Bloch et al. 2011; Leipzig et al. 1999; 
Woolcott et al. 2009), as well as anti-hypertensive medication increases fall risk in older adults 
(Leipzig et al. 1999; Woolcott et al. 2009). Two other systematic reviews found similar findings 
(Hartikainen et al. 2007; Park et al. 2015). However, these meta-analyses and reviews included 
studies with older adults living in institutional settings where medication use and the number of 
falls is substantially higher compared to the general population. For example, anti-depressants 
use, specifically selective serotonin reuptake inhibitors (SSRIs) are used by 36.1% of long-term 
care older adults compared to 9.5% of community dwelling older adults (CIHI, 2012). 
Additionally, approximately one in three community dwelling older adults fall at least once per 
year (Chang et al. 2015; Gill et al. 2005; O’Loughlin et al. 1993; Tinetti et al. 1988) compared to 
46% of long-term care residents (Rojas-Fernandez, 2015).  
In community dwelling older adults (defined as individuals aged 60 years and older 
living independently), prescription use is common with 83 to 90% using at least one medication 
(Rotermann et al. 2015; National Center for Health Statistics, 2016; Scholes et al. 2013). 
Psychotropic medications including anti-psychotics, anti-depressants, as well as anti-
hypertensive medications are some of the most commonly prescribed medications to community 
dwelling older adults (Rotermann et al. 2015; Merel et al. 2017; National Center for Health 
Statistics, 2016; Scholes et al. 2013).   
Anti-psychotics are categorized as typical (first-generation) or atypical (second-
generation). First generation anti-psychotics were developed in the 1950s (Ramachandraiah et al. 
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2009) and are prescribed to treat schizophrenia. Second generation anti-psychotics, developed in 
the 1990s and are more commonly prescribed to treat insomnia and symptoms of dementia (e.g. 
hallucinations, delusions) (Ramachandraiah et al. 2009). Compared to second generation 
medications, first generation medications have more severe side effects including drowsiness, 
agitation, muscle stiffness or spasms, and blurred vision (CAMH, 2012). However, the side 
effects of second generation anti-psychotics can also elevate fall risk from increased sedation and 
hypotension (CIHI, 2014).  
Anti-depressants are primarily used to treat depression. The most common anti-
depressants prescribed to older adults are selective serotonin reuptake inhibitors (SSRI), tricyclic 
anti-depressants (TCA) and selective norepinephrine reuptake inhibitors (SNRIs). Side effects of 
anti-depressants include orthostatic hypotension, sleep disturbance, daytime drowsiness and 
sedation, and can contribute to falls (Darowski et al. 2009). Previous reviews have found that 
anti-depressants are associated with falls, however, the included studies had samples with both 
community dwelling and institutionalized older adults, which were never examined separately 
(Haritkainen et al. 2007; Leipzig et al. 1999; Woolcott et al. 2009).  
Hypertension or high blood pressure is treated with anti-hypertensive medications. Side 
effects related to anti-hypertensive medication use include dizziness, poor balance and gait, and 
postural hypotension which can cause falls (Gandhi et al. 2003; Gurwitz et al. 2003; Gray et al. 
1999; Field et al. 2004; Gray et al. 1998; Tinetti et al. 2014). However, findings concerning 
whether anti-hypertensive medications are associated with fall risk are limited and mixed. For 
example, a review found anti-hypertensive medication use was associated with falls in both 
community dwelling and institutionalized older adults (Woolcott et al. 2009), however, a second 
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review of community and LTC older adults concluded use of anti-hypertensive medications and 
falls was mixed (Park et al. 2015) 
The World Health Organization recognizes alcohol as a risk factor for falls (WHO, 
2007); however, few studies have examined alcohol use as a risk for falls in community dwelling 
older adults. Alcohol use in older adults is common ranging from 63% to 81% (Cousins et al. 
2014; Du et al. 2016; Bye & Rossow, 2017). Physiological changes related to aging may increase 
sensitivity to alcohol use in older adults. Additionally, the combined use of alcohol with either 
psychotropic, anti-depressants and anti-hypertensive use can result in increased sedation, 
psychomotor impairment, drowsiness, hypotension and disorientation, resulting in increased risk 
of falls (Moore et al. 2007; Weathermon and Crabb, 1999). 
 To date, there has been no literature reviews that have synopsized the literature 
pertaining to whether anti-psychotics, anti-depressants and anti-hypertensives are associated with 
an increased fall risk in community dwelling older adults. While medications such as 
benzodiazepines, anti-psychotics, anti-depressants, and anti-hypertensives have been associated 
with falls in prior reviews, the samples included older adults living in long-term care and few 
studies have examined alcohol use when taking medication as a predictor of falls. Thus, the 
objective of this study is to synthesize peer-reviewed studies that examined psychotropic 
(including benzodiazepines, hypnotics/sedatives, anti-psychotics, anti-depressants, and anti-
hypertensive medications), both singularly and in combination with alcohol, on fall risk in 






2.2.1 Search Strategy 
We searched for peer-reviewed primary studies that examined anti-
psychotic/benzodiazepines, anti-depressant, anti-hypertensive medications, as well as alcohol, 
both singly and in combination, on fall risk in community dwelling older adults. In consultation 
with the university librarian, four electronic databases were searched (e.g., PUBMED, 
EMBASE, CINAHL and SCOPUS). An initial search was conducted in November 2016 with a 
follow-up search in December 2017 for any new articles that might have been published. We 
also searched for grey literature using the World Health Organization IRIS search engine, Public 
Health Agency of Canada search engine, Canadian Institute of Health Information, and the 
Canadian Agency for Medications and Technologies in Health, but no studies in the grey 
literature were included as they did not meet the inclusion criteria. Articles/reports were included 
if they were: 1) a primary study; 2) included community-dwelling persons aged 60 years or older 
3) included alcohol consumption as an independent variable; 4) included medications of interests 
(i.e. psychotropics, benzodiazepines, hypnotics/sedatives, anti-psychotics or anti-depressants, 
and anti-hypertensives); 5) falls as an outcome variable; and 6) were published in English. 
Studies with samples having a large age range (e.g. 18-97 years) were included if authors 
performed specific analyses in older adults aged 60 years and older. Articles were excluded if 
they were: 1) review articles, conference proceedings, books, editorial, case studies or 
commentary; 2) if articles relied on qualitative data (interviews, focus groups); 3) if they were 
not in English; and 4) included institutionalized persons (e.g. living in LTC or hospital). Studies 
defining alcohol consumption as alcohol misuse were excluded because it is unknown if 
participants were current consumers of alcohol.  
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A general search was performed using each medication class of interest (e.g. 
psychotropic medication or benzodiazepine or anti-psychotic, anti-depressant medication, anti-
hypertensive medication) using the following terms: drug or medication, aged or elderly or older 
adult or senior, accidental falls or falls or falling, and alcohol or alcohol drinking. Each 
medication class was also used to search medical subject headings (MeSH) such as: accidental 
falls, alcohol drinking/ adverse effects, alcohol drinking/ drug effects and aged. 
2.2.2 Study Selection 
As shown in Figure 1, the search yielded 1,146 sources of literature. Using a database 
management system (RefWorks), 505 duplicates were removed. The Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) framework was used to track the number 
of articles identified in each stage of the review (identification, screening, eligibility and 
included articles) (Moher et al. 2009). After duplicate articles were removed, article titles and 
abstracts were screened for potential full-text review using the inclusion and exclusion criteria. 
Five hundred and ninety-eight records were removed because the articles: 1) were not in English 
(n=1); 2) were review articles, reports, books, editorial, case studies or commentary (n=383); 3) 
falls was not an outcome variable (n=208); 4) included persons living in institutionalized care 
(n=4); and 5) did not perform any analysis in older adults (n=2). After full text review, twenty-
nine articles were included. The reference list of the selected articles and previous literature 
reviews were searched for additional studies that might be relevant. 
2.2.3 Data Extraction 
Included articles had relevant information extracted and entered into a table. Table 1 
summarizes the following information for each article: study title, first author, year published, 
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country, study objective, design and methods, inclusion and exclusion criteria, sample 
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Table 1. Studies on alcohol and psychotropic, anti-depressant, and anti-hypertensive medication use on fall risk in community 
dwelling older adults 
Authors (year), 
Title, Country 





Sample Size  
& Characteristics 
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Hanlon et al. 
2009 
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of CNS medications 
at years 1,2,3 and 5, 
number of CNS 
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dosage, pain, severe 
depression, cognitive 
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>2 falls within 
the past year 
(comparison 




doses (>3 doses) 
(OR= 2.89; 95% CI 
1.96-4.25; p<.0001), 
and use of 2+ CNS 
medications 
(OR=1.95; 95% CI 
1.35-2.81; p<.001) 
 
Both long and short 
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alcohol and CNS 








Age, marital status, 
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study  
 
































was found between 
users of psychoactive 
and non-users.  
 
Females taking two 
psychoactive 
medications were 
2.17x more likely to 
fall, and those taking 
one psychoactive 
medication were 
1.25x more likely to 
fall compared to non-
users (2= 4.60, 
p<0.05).   
 
Use of hypertensive 
medications were not 
associated with falls.  
 
Alcohol consumption 
was not significantly 














Mean age = 73.7 
±6.3 




Single fall Users of one 
psychoactive 
medication were 
2.08x more likely to 
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function and falls 
in older females. 
 




















number of alcoholic 
drinks per week, 
cognitive status, 
medical conditions  
 




8.99x more likely to 
fall compared to 
those not taking 
medications  
   
Users of long-acting  
BZN were 7.03x 
likely to report 
recurrent falls (95% 
CI 2.12-23.28). Short 
acting BZN did not 




2.84x likely to report 
recurrent falls (95% 
CI 1.00-8.02).   
Psychoactive 
medication use was 
an independent risk 








medications was not 
associated with falls. 
Alcohol and 
benzodiazepines 











examined sub-sample of 












by a fall 
3) visited 











>70 years, N=299  
 
 
Age, sex, severity of 
injury, blood alcohol 
concentration, 
benzodiazepine 
blood sample  
 
 
Injurious fall Falls due to alcohol 
was more common in 
males compared to 
females (p<0.001).  
 
BZN use and falls 
were not significantly 
associated with falls 
among males and 
females. 
 
No males or females 
tested positive for 
both alcohol and 
BZNs at the time of 
the fall.  






11 years follow-up; 
examined sub-sample of 
Inclusion: 




Age range: 20 to 
92 




Injurious fall Males who consumed 
>1000g of alcohol per 
month had an 8.45x 
greater risk of an 
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death in a cohort 
of 19,500 adults 
 

















Mean age: 45; SD 
not reported 
 
N (>60) =3909 







conditions, and prior 
injuries 
injurious fall (95% CI 
2.47-28.89) compared 
to those who 
consumed 500-999g 





of alcohol per month 
had 14.42x the risk of 
an injurious fall (95% 
CI 1.19-110.16) 
compared to those 
who consumed less 
(≥99g) (RR=0.83; 




medications had 2.9x 
the risk of injurious 
falls (95% CI 1.15-





medications had 1.7x 
the risk of injurious 
falls (95% CI 1.09-
2.68) compared to 
non-users.  
Association 





other risk factors 
and a single 
















examined sub-sample of 





Health of the Population 
Study.  
Inclusion:  












Mean age±SD not 
reported 
 





Age, sex, health, 
living conditions, 
alcohol consumption 





injurious falls  
High levels of alcohol 
consumption 
(500+g/month) was 
not associated with 
falls in men >60 years 
of age.  
Among males ≥60, 
use of hypnotics or 
sedatives was not 
associated with falls 
(RR=0.87; 95% CI 
0.48-1.74). 
 
Females ≥60 years of 
age who consumed 
high levels of alcohol 
and used sedatives 
had 2.13x and 1.50x 
the risk of having an 
injurious fall, 
respectively (95% CI 
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Users of SSRIs were 
1.55x more likely to 
report a single fall 
(95% CI 1.26-1.90), 
1.66x more likely to 
report recurrent falls 
(95% CI 1.36-2.02) 
and 1.52x as likely to 
report an injurious 
fall (95% CI  
1.25-1.84). 
 
Females >80 years 
with depressive 
symptoms and taking 
anti-depressants were 
1.85x as likely to 
report recurrent falls 
(95% CI 1.17-2.93), 
and 2.59x as likely to 
report injurious falls 
(95% CI 1.65-4.37) 
compared to those 
without depressive 
symptoms.   
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Females >80 years 
with depression and 
users of SSRIs were 
3.96x more likely to 
report injurious falls 
(95% CI 2.13-7.36) 
compared to those 
without depression 




with falls among 
older adults in 
Germany 
 





Data obtained from 
National Health 
Interview and 






























Single fall and 
recurrent falls 
(>2) 
Use of psychotropic 
medications overall 
was associated with 
higher risk of falls 
(OR=1.64; 95% CI 
1.14-2.37). 
 
Use of synthetic anti-
depressants and 
specifically SSRIs 
increased fall risk by 
2.66x and 6.22x, 
respectively (95% CI 





consumption was not 






and the risk of 
falls in older 
adults 
 




Case-control and case 
series 
 
Data obtained from the 
Health Improvement 
Network (primary care 
database). 
Inclusion: 























Controls= 52, 100 
 
Mean age cases= 




















of SNRI, SSRI, TCA 
(never, previously, 
recently, currently). 
Single fall Increased risk of falls 
within 28 days of first 
prescription of SNRI 
(OR=1.79; 95% CI 
1.42-2.25); SSRI 
(OR=2.04; 95% CI 
1.86-2.24); TCA 
(OR=1.61; 95% CI 
1.46-1.76). 
 
Falls were 2.5x 
higher in those y 
prescribed a SNRI; 
2.04x higher in those 
prescribed an SSRI; 
and 1.61x higher in 
those prescribed a 
TCA compared to 
non-users. Risk of 
falls increased with 




multiple falls in 
elderly people: 
the St Louis 
OASIS study  
 
Cumming et al. 
1991 
 












N=1, 358  
 















life events, vision, 
hearing, alcohol use, 
exercise, medication 
use (over the counter 
and prescribed). 
2 or more falls Diazepam use 
resulted in 3.7x 
greater risk of 
recurrent falls; use of 
anti-hypertensives 
diltiazem and diuretic 
use resulted in 1.8x 




Increased dose of 
diazepam (>2.5mg 
per day) was 
associated with a 
10.8x greater risk of 
having recurrent falls.  
 
Increased dose of 
diltiazem (>180mg 
per day) was 
associated with a 10x 
greater risk of having 
recurrent falls. 





Inclusion: N= 321,322 
Mean age± SD not 
reported 






Fall risk in older 
adults within first 
four weeks of using 
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use and falls: the 
time factor 
 
















Cases (>60) BZN 
sedatives= 35,308 
 












history of treatment 
for 
alcohol/medication 
abuse preceding 12 
months, presence or 




BZN (OR=4.0; 95% 
CI 2.4-6.6) in males 
and (OR=2.3; 95% CI 
1.7-3.2) in females; 
BZN tranquillizers in 
older adults increased 
fall risk in males 
(OR=2.5; 95%CI 1.4-
4.3) and females 






persons >60 years: 
Triazolam (OR=2.7; 
95% CI 2.0-3.6); 
Flurazepam (OR=3.4; 
95% CI 2.5-4.7); 
Diazepam (OR=1.8; 
95% CI 1.3-2.5); 
Lorazepam (OR=2.0; 
95% CI 1.3-3.1); 
Oxazepam (OR=2.2; 
95% CI 1.4-3.4). 
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Persons ≥80 years 
and using BZN 
sedatives had 
hospitalization fall 
rates from BZN 
sedatives and 
tranquilizer use (94.5 
per 10,000 and 52.8 




well-being is an 
independent 
predictor of 
falling in an 8-
year follow-up of 
older adults 
 







Study of Ageing 
Inclusion: 


















Age, sex, education, 
mini-mental state 
exam score, visual 









of alcohol use, 
psychological well-
being 
Single fall and  
2 falls 
Psychotropic use was 




and falls was 
dependent on level of 
consumption:  
2-3 drinks per week 
increased recurrent 
fall risk by 1.24x 
(95% CI 1.06-1.46) 
and 4 drinks per 




Falls risk among 




























alone, recurrent falls 
in previous years, 
sedentary physical 
activity in previous 
year, self-rated 
physical and mental 
health, symptoms of 
anxiety/nervousness 
or fear of falling, 
sleeping problems, 
breathlessness, poor 
vision when moving, 
short geriatric 
depression score 7, 
mini mental state 
exam score, lower 
extremity 
performance score, 










2.15x more likely to 
fall (95% CI 1.36-
3.40); users of 
hypnotics were 1.40x 
more likely to fall 
(95% CI 1.10-1.79); 
and users of 
antidepressants were 
1.82x more likely to 
fall (95% CI 1.32-




medications were not 























1) were 85 









Sex, marital status, 
education, living 
alone, visual and 
hearing impaired, 









Gijon test, activities 
of daily living and 
instrumental 
activities of daily 
living, cognitive 
status, quality of life, 
gait, nutrition, 
psychotropic 
medication use, total 
number of 
medications 
Single fall Psychotropic 
medication use was 
not associated with 
falls.  
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Do older adults 
with cancer fall 
more often? A 
comparative 
analysis of falls 
in those with and 
without cancer 
 
















































Age, sex, race and 
ethnicity, marital 
status, lives with 
someone time alone 






vision, weight loss, 
pain, comorbidities, 






fall risk (OR=1.29; 
95% CI 1.19-1.40) 
compared to non-
users (diagnosis of 





hypnotics were not 

















Use of CNS 





Users of SSRIs 
(OR=3.1; 95% CI 
2.0-5.0); TCAs 
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aged 60-75 years: 




Masud et al. 2013 
 
Denmark  




(OR=2.2; 95% CI 
1.0-4.7); and 
BZN (OR=1.5; 95% 
CI 0.9-2.6) resulted in 





recurrent falls were 
more likely to be 
taking anti-
depressants (OR=2.9; 
95% CI 1.8-4.8), 
specifically SSRIs 
(OR=3.1; 95% CI 
1.8-5.6); and BZN 
(OR=2.3; 95% CI 
1.2-4.3). 
 























Single fall Non-fallers were 




fewer falls over 























ACEi, ASBMs, BB, 








95% CI 0.48-0.97) 
compared to fallers. 
Fallers were more 
likely to use 
psychotropic 
medications 
(OR=1.68; 95% CI 
1.11-2.53) compared 
to non-fallers. 
Risk factors for 
serious fall 
related injury in 
elderly females 
living at home  
 


















Activities of daily 
living and disability 
in instrumental 
activities of daily 
living, medications 
(anti-hypertensives), 










risk of injurious falls 







inability to climb 
more than 30cm 
step, arthrosis of the 
hip, inability to get 
up from floor, 
maximum walking 


















1) aged 66 
years and 
older 















Medication use 30 
days prior to the fall 
(anti-histamines, 














injurious fall risk by 









medication use was 
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sex, median income, 
hospitalization 
within previous year, 
comorbidities 
not associated with 
injurious falls.  
Fall-risk 
screening test: a 
prospective study 



























Mean age S.D= 
75.26.5  
 
Age, sex, living 
situation, education, 
urbanization, BMI, 
height and weight, 
diagnosis of chronic 
disease (COPD, 





medication use, Mini 




vision and hearing, 
level of activity, 





a significant predictor 
for any falls (OR=1.6; 
95% CI 1.1-2.2), but 
not recurrent falls 
(OR=1.4; 95% CI 
0.9-2.2). 
 
Alcohol was not 
associated with falls. 
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ability to walk, 
alcohol, smoking, 
fear of falling. 
Predictors of falls 












































function, level of 
activity, body weight 
and height 





medication use was 
associated with any 
fall (OR=1.4; 95% CI 
1.0-1.9) and recurrent 
fall risk (OR=1.6; 
95% CI 1.1-2.3). 
 
Users of sedatives 
were 1.8x more likely 
to experience an 
injurious fall 
compared to non-
users (95% CI 1.0-
3.3).  
 
Alcohol was not 
associated with falls.  
Psychotropic 
medications and 
risk for falls 







Age, sex, marital 
status, living alone, 
activities of daily 
Single fall 
within 90 days 
of assessment 
Use of psychotropics 
was associated with a 





older people: an 
observation study  
 


























falls (adjusted OR: 
1.47; 95% CI 1.24-




users, fall risk was 








95% CI 1.00-2.11); 
BZN (long-acting) 
(OR=1.45; 95 % CI 
1.00-2.19) 
BZN (short-acting) 




were not associated 






risk for falls in 
older females   
 
Ensrud et al. 2002 
 




















BZN users  










dizziness, history of 








activities of daily 
living, Mini-Mental 












users, users of BZN 
and anti-depressants 
were 1.51x and 1.54x 
more likely to have 
recurrent falls (95% 
CI 1.14-2.01), (95% 
CI 1.14-2.07), 
respectively. Use of 
anti-depressants 
increased fall risk by 
54%. 
 
Females using short 
or long acting BZN 
had an increased risk 
of recurrent falls 
compared to non-
users (OR=1.42; 95% 
CI 0.98-2.04) and 




users, users of SSRIs 
were more likely to 
have recurrent falls 
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by 3.45x (95% CI 
1.89-6.30).  
 
TCAs were not 
associated with falls.  






Hanlon et al. 
2002 
 

















Age, race, sex, 
income, educational 
in years, urban/rural 
residence, smoking, 
alcohol use, BMI, 
number of 
disabilities, self-
rated health, sleep 
difficulty, chronic 
disease (arthritis, 















users, BZN use was 
as associated with 
single and recurrent 
falls (crude OR=1.50; 
95% CI 1.14-1.96). 
 
Anti-hypertensives 
(e.g. diuretics) and 
other cardiac 
medications were not 
associated with falls.  
 
Alcohol was not 









Is a fall just a fall: 
correlates of 
falling in health 
older persons. 





de Rekeneire et 
al. 2003 
 
United States  
Cross sectional survey 
 
Health, Aging and Body 















Sex, race, functional 
















BZN use was 
associated with a 
history of falls (OR= 
1.6; 95% CI 1.0-2.6) 
in females, but not 
males.  
 
Falls in 84- to 85-
year old people 
living at home 
 





1) aged 84 






Sex, marital status, 
living situation, 
activities, smoking, 
need of community 
service, dizziness, 
Single fall Anti-depressant use 
was an independent 










quality of night 
sleep, well-being and 
tiredness, hearing 
function, heart rate 
and blood pressure, 
balance tests, 





(i.e. diuretics)) Mini 
Mental State Exam.   
Sedatives/hypnotics, 
and anti-hypertensive 
medications were not 
associated with falls. 
 
 
Falls by elderly 




Blake et al. 1988 
 
United Kingdom 












Age, sex, reason for 
fall, poor vision or 


















associated with falls 
(2=7.16, p<0.01; 
and 2=4.39, p<0.05). 













Risk factors for 
falls among 
elderly persons 
living in the 
community  
























Age, sex, race, living 
situation, activities 
of daily living, 
balance and gait 
assessment, BMI, 





hospitalized in past 
year, urinary 
incontinence, use of 
cane or walker, 
physical activity, 





Single fall Use of sedatives 
increased fall risk by 
2.5x after controlling 
for cognitive 
impairment (95% CI 
1.6-3.9) and by 2.0x 
after controlling for 
depression (95% CI 
1.3-3.0). 
 
Individually, use of 
sedatives increased 
fall risk by 28.3x 
(95% CI 3.4-239.4). 
Alcohol use was not 







injuries in a 
nationally 
representative 
sample of older 
adults  
 
































dependent in basic or 
instrumental 











ARB, BB, CCB, 
centrally acting 




serious falls (adjusted 
hazard ratios=1.40; 
95% CI 1.03-1.90). 
 
Use of high dosage 
anti-hypertensives 
was not associated 
with serious falls 
(adjusted hazard 
ratios=1.28; 95% CI 
0.91-1.80).  
 
Those with a history 




more likely to have a 
serious fall (adjusted 
hazard ratio= 2.31; 
95% CI 1.01-5.29) 
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antiadrenergic 





users (adjusted hazard 
ratio= 2.17; 95% CI 
0.98-4.80). 
Footnotes: CVD: cardiovascular disease; COPD: chronic obstructive pulmonary disease; BZN: benzodiazepine; CNS; Central 
Nervous System; MAOI: monoamine oxidase inhibitors; MAOI-A: monoamine oxidase inhibitors; SSRIs: selective serotonin 
reuptake inhibitors; ACEi: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blockers; ASBMs: angiotensin 
system-blocking medication; BB: beta-blocker; CCBs: calcium channel blockers; BMI: Body Mass Index; OR: Odds ratio; RR: 




2.3.1 Description of Primary Studies  
        As shown in Table 1, studies were published between 1988 and 2017. Sample sizes 
ranged from 307 to 321,422. Sixteen studies had follow-up periods, ranging from 11 months to 
12 years (Anstey et al. 2008; Bergland et al. 2004; Ensrud et al. 2002; Gribbin et al. 2011; 
Hanlon et al. 2002; Hanlon et al. 2009; Iinattiniemi et al. 2009; Lord et al. 1995; Malmivaara et 
al. 1993; Stenbacka et al. 2002; Svensson et al. 1992; Tinetti et al. 1988; Tinetti et al. 2014; 
Tromp et al. 1998; Tromp et al. 2001; Wong et al. 2013). Four studies included samples with 
females only (Bergland et al. 2004; Ensrud et al. 2002; Lord et al. 1993; Lord et al. 1995), one 
study included males only (Masud et al. 2013); the other 22 studies had samples with mixed sex 
composition. Five studies were conducted in Australia (Anstey et al. 2008; Kerse et al. 2008; 
Lord et al. 1993; Lord et al. 1995; Wong et al. 2013), fourteen in Europe (Bergland et al. 2004; 
Blake et al. 1988; Du et al. 2017; Ferrer et al. 2012; Gribbin et al. 2011; Iinattiniemi et al. 2009; 
Kurzthaler et al. 2005; Landi et al. 2005; Malmivaara et al. 1993; Masud et al. 2013; Stenbacka 
et al. 2002; Svensson et al. 1992; Tromp et al. 1998; Tromp et al. 2001), eight in the United 
States (Cumming et al. 1991; de Rekeneire et al. 2003; Ensrud et al. 2002; Hanlon et al. 2002; 
Hanlon et al. 2009; Spoelstra et al. 2013; Tinetti et al. 1988; Tinetti et al. 2014); and two in 
Canada (Kelly et al. 2003; Neutel et al. 1996). 
Eleven studies conducted surveys (Anstey et al. 2008; Blake et al. 1988; Cumming et al. 
1991; Kerse et al. 2008; Lord et al. 1993; Masud et al. 2013; Stenbacka et al. 2002; Svensson et 
al. 1992; Tinetti et al. 2014; Tromp et al. 1998; Tromp et al. 2001); fourteen studies conducted 
both a survey and a clinical assessment (e.g. height, weight, blood pressure, Mini Mental State 
Examination) (Bergland et al. 2004; de Rekeneire et al. 2003; Du et al. 2017; Ensrud et al. 2002; 
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Ferrer et al. 2012; Hanlon et al 2002; Hanlon et al. 2009; Iinattiniemi et al. 2009; Landi et al. 
2005; Lord et al. 1995; Malmivaara et al. 1993; Spoelstra et al. 2013; Tinetti et al. 1988; Wong et 
al. 2013), two studies relied on hospital records for data (Gribbin et al. 2011; Neutel et al. 1996), 
one study relied on a regional database (Kelly et al. 2003), and one study relied on blood samples 
(Kurzthaler et al. 2005).  
Studies examined single falls, recurrent falls or both. Four studies examined single falls 
(Ferrer et al. 2012; Gribbin et al. 2011; Landi et al. 2005; Svensson et al. 1992), twelve examined 
recurrent falls (Blake et al. 1988; Cumming et al. 1991; de Rekeneire et al. 2003; Du et al. 2017; 
Ensrud et al. 2002; Hanlon et al. 2009; Iinattiniemi et al. 2009; Lord et al. 1993; Spoelstra et al. 
2013; Tromp et al. 1998; Tromp et al. 2001; Wong et al. 2013), and six examined both single and 
recurrent falls (Anstey et al. 2008; Hanlon et al. 2002; Kerse et al. 2008; Lord et al. 1995; Masud 
et al. 2013; Tinetti et al. 1988). Seven studies had a primary outcome of fall related injury, 
hospitalization or death (Bergland et al. 2004; Kelly et al. 2003; Kurzthaler et al. 2005; 
Malmivaara et al. 1993; Neutel et al. 1996; Stenbacka et al. 2002; Tinetti et al. 2014).  
2.3.2 Anti-Psychotics/Benzodiazepines 
 Twenty-six studies examined whether psychotropic medications increased fall risk: 
sixteen cohort (Anstey et al. 2008; Cumming et al. 1991; Ensrud et al. 2002; Hanlon et al. 2002; 
Hanlon et al. 2009; Iinattiniemi et al. 2009; Lord et al. 1993; Lord et al. 1995; Malmivaara et al. 
1993; Neutel et al. 199; Spoelstra et al. 2013; Stenbacka et al. 2002; Tinetti et al. 1999; Tromp et 
al. 1998; Tromp et al. 2001; Wong et al. 2013); nine cross-sectional studies (Blake et al. 1988; de 
Rekeneire et al. 2003; Du et al. 2017; Ferrer et al. 2012; Kerse et al. 2008; Kurzthaler et al. 2005; 
Landi et al. 2005; Masud et al. 2013; Svensson et al. 1992) and one case-control (Kelly et al. 
2003). Sample sizes ranged from 328 to 321,422. Fourteen studies defined falls as “falling to the 
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ground unintentionally” (Bergland et al. 2004; Cumming et al. 1991; Du et al. 2017; Ensrud et al. 
2002; Ferrer et al. 2012; Hanlon et al. 2009; Kerse et al. 2008; Landi et al. 2005; Lord et al. 
1993; Lord et al. 1995; Tinetti et al. 1988; Tromp et al. 1998; Tromp et al. 2001; Wong et al. 
2013), twelve did not provide a definition of falls. 
Nineteen studies found that psychotropic medication use significantly increased fall risk 
after controlling for age (Blake et al. 1988; Cumming et al. 1991; de Rekeniere et al. 2003; Du et 
al. 2017; Ensrud et al. 2002; Hanlon et al. 2002; Hanlon et al. 2009; Iinattiniemi et al. 2009; 
Landi et al. 2005; Lord et al. 1993; Lord et al 1995; Malmivaara et al. 1993; Masud et al. 2013; 
Neutel et al. 1996; Stenbacka et al. 2002; Tinetti et al. 1988; Tromp et al. 1998; Tromp et al. 
2001; Wong et al. 2013); one study did not control for age but a significant association was 
found between psychotropic medication use and falls (Spoelstra et al. 2013); six studies found no 
association (Anstey et al. 2008; Ferrer et al. 2012; Kelly et al. 2003; Kerse et al. 2008; 
Kurzthaler et al. 2005; Svensson et al. 1992).  
2.3.2.1 Anti-Psychotics/Benzodiazepines and Single Falls 
 Between 9% and 58.7% of single fallers were taking some form of psychotropic 
medication. Anti-psychotics, hypnotics and anxiolytics were not associated with single falls; 
however, other CNS medications (not defined) significantly increased fall risk by 1.22x (Kerse et 
al. 2008). In contrast, anti-psychotics, both first generation and second generation were used by 
up to 9.4% of single fallers and were found to be associated with falls (Landi et al. 2005). One 
study found sedative use increased fall risk by 2.5x after controlling for cognitive impairment 
and 2.0x after controlling for depression (Tinetti et al. 1988). Fall risk in users of psychotropic 
medications was not stated in one study (Ferrer et al. 2012).  
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2.3.2.2 Anti-Psychotics/Benzodiazepines and Recurrent Falls 
Users of psychotropic medications were 64% more likely to have recurrent falls 
compared to non-users, and 1.84x more likely to experience recurrent falls compared to non-
users (Du et al. 2017). Two studies found females using benzodiazepines were more likely to 
experience recurrent falls compared to non-users (de Rekeneire et al. 2003; Ensrud et al. 2002). 
Fall history was also associated with prospective falls. For example, in a study of females, users 
of benzodiazepines were 1.51x more likely to experience recurrent prospective falls compared to 
non-users (Ensrud et al. 2002). Similarly, males using benzodiazepines were 2.3x more likely to 
have recurrent prospective falls compared to non-users (Masud et al. 2013).  
Overall use of central nervous system medications increased the risk of recurrent falls by 
1.55x (Hanlon et al. 2009). Furthermore, while benzodiazepines predicted single falls (OR=1.6; 
95% CI 1.1-2.2), they were not predictive of recurrent falls (2) in a prospective cohort study 
(Tromp et al. 2001). Specific types of anti-psychotics or benzodiazepines may increase recurrent 
fall risk. For example, diazepam resulted in a 3.7x greater risk of recurrent falls compared to 
non-users (Cumming et al. 1991) and anti-psychotics increased recurrent fall risk by 1.66x. One 
study found that hypnotics and anxiolytics were not associated with falls in the multivariate 
analysis (Iinattiniemi et al. 2009).   
2.3.2.3 Anti-Psychotics/Benzodiazepines and Injurious Falls 
Injurious falls were defined as a fall resulting in a fracture, emergency room visit, or 
hospital admission. One study found that sedative use increased fall-related fractures by 1.8x 
compared to non-injurious and recurrent falls (Tromp et al. 1998). Four studies compared sex, 
psychotropic medication use and hospitalization rates. (Kurzthaler et al. 2005; Malmivaara et al. 
1993; Neutel et al. 1996; Stenbacka et al. 2002). A longitudinal study found males using 
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benzodiazepines medications (individual medications not reported) were 2.9x more likely to 
have an injurious fall compared to non-users; and females were 1.7x more likely to have an 
injurious fall compared to non-users (Malmivaara et al. 1993). Similarly, males using a 
benzodiazepine sedative or tranquilizer were 4.0x more likely to be hospitalized due to falls 
compared to non-users; and females were 2.5x more likely to be hospitalized due to falls 
compared to non-users, respectively (Neutel et al. 1996). One study reported females >60 years 
using hypnotics/sedatives were 1.5x more likely to have an injurious fall resulting in 
hospitalization compared to males (Stenbacka et al. 2002). One study found no differences 
between sex and the use of benzodiazepines on injurious fall risk (Kurzthaler et al. 2005). Use of 
anti-psychotics was not associated with fall-related emergency room visits in one study (Kelly et 
al. 2003). Additionally, a cohort study found no association between injurious falls and 
anxiolytic, anti-psychotic, hypnotic or other central nervous system medication use (Kerse et al. 
2008).  
2.3.2.4 Short vs Long-Acting Anti-Psychotics 
Five studies examined the effects of short and long-term anti-psychotics or 
benzodiazepines on fall risk (Cumming et al. 1991; Ensrud et al. 2002; Landi et al. 2005; Lord et 
al. 1995; Neutel et al. 1996). Short acting benzodiazepines (e.g. alprazolam, temazapam, 
oxazepam) were not associated with increased risk of single or recurrent falls in two studies 
(Cumming et al. 1991; Lord et al. 1995). However, one study found oxazepam, a short acting 
anti-psychotic increased the risk of fall-related hospitalizations by 2.2x and one study found 
short-acting benzodiazepines increased fall risk by 1.3x (Landi et al. 2005; Neutel et al. 1996). 
Females ≥65 years and using short benzodiazepines had a 1.42x greater risk of recurrent falls 
compared to non-users (Ensrud et al. 2002). Use of short-term CNS medications (duration not 
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stated) was also significantly associated with recurrent falls (p<0.05), however, authors did not 
state which benzodiazepines were examined (Hanlon et al. 2009).   
Older adults using long acting benzodiazepines had a 2.18x greater risk of recurrent falls, 
and in particular, users of diazepam had 3.7x greater risk compared to single or non-fallers 
(Cumming et al. 1991). Users of long-acting benzodiazepines were 1.45x more likely to fall 
compared to non-users (Landi et al. 2005). Females ≥65 years taking long-acting 
benzodiazepines (e.g. diazepam) were 7.03x more likely to fall compared to females taking 
short-acting benzodiazepines (Lord et al. 1995). Similarly, females ≥65 years and using long-
acting benzodiazepines had a 1.56x greater risk of recurrent falls compared to non-users (Ensrud 
et al. 2002). Furthermore, long-term usage (for two continuous years) of CNS medications was 
found to be significantly associated with recurrent falls (p<0.05), however, authors did not state 
which benzodiazepines were examined (Hanlon et al. 2009).   
2.3.2.5 Multiple Medication Use 
Multiple psychotropic medication use was associated with falls in three studies (Hanlon 
et al. 2009; Lord et al. 1993; Lord et al. 1995). In females, users of one and two or more 
psychoactive medications were 1.25x and 2.17x more likely to fall compared to non-users (Lord 
et al. 1993). Similarly, Lord et al. (1995) also found that females taking two or more 
psychoactive medications were 8.99x more likely to fall compared to non-users, and those taking 
one psychoactive medication were 2.88x more likely to fall compared to non-users. Older adults 
using two or more CNS medications were 1.95x more likely to experience recurrent falls 




2.3.2.6 Anti-psychotic Dosages 
Two studies examined the effect of dosages on fall risk. Users of CNS medications taking 
3 or more standard doses/day had a 2.89x higher risk of having recurrent falls compared to those 
who took less than 2 standard doses per day (Hanlon et al. 2009). Another study found those 
taking < 2.5mg of diazepam per day were more likely to have recurrent falls than non-users 
(odds ratio not stated) and those taking >2.5mg of diazepam were 10.8x more likely to have 
recurrent compared to non-users (Cumming et al. 1991).  
2.3.3.1 Anti-depressants  
Thirteen studies examined anti-depressant medication use as a risk factor for falls (Blake 
et al. 1988; Cumming et al. 1991; Du et al. 2017; Ensrud et al. 2002; Gribbin et al. 2011; 
Iinattiniemi et al. 2009; Kelly et al. 2003; Kerse et al. 2008; Landi et al. 2005; Lord et al. 1995; 
Masud et al. 2013; Spoelstra et al. 2013; Svensson et al. 1992). Sample sizes ranged from 414 
(Lord et al. 1995) to 21,900 (Kerse et al. 2008). Five studies were cohort (Cumming et al. 1991; 
Ensurd et al. 2002; Iinattiniemi et al. 2009; Lord et al. 1995; Spoelstra et al. 2013), six were 
cross-sectional (Blake et al. 1988; Du et al. 2017; Kerse et al. 2008; Landi et al. 2005; Masud et 
al. 2013; Svensson et al. 1992), and two were a case-control and/or case series analysis (Gribbin 
et al. 2011; Kelly et al. 2003). Six studies defined falls as “falling to the ground unintentionally” 
(Cumming et al. 1991; Du et al. 2017; Ensrud et al. 2002; Kerse et al. 2008; Landi et al. 2005; 
Lord et al. 1995). One study defined falls as a ‘fall-accident’ (Gribbin et al. 2011). Ten studies 
found anti-depressant use significantly increased fall risk in older adults (Blake et al. 1988; Du et 
al. 2017; Ensrud et al. 2002; Gribbin et al. 2011; Kelly et al. 2003; Kerse et al. 2008; Lord et al. 
1995; Masud et al. 2013; Spoelstra et al. 2013; Svensson et al. 1992). Two studies found anti-
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depressants were associated of falls, however, the odds ratios were not stated (Blake et al. 1988; 
Svensson et al. 1992).  
2.3.3.2 Anti-Depressants and Single Falls 
The prevalence of anti-depressant use in single fallers ranged from 2.2%-18.9%. Previous 
prescription of anti-depressants such as SNRIs, SSRIs and TCAs were associated with single 
falls (Gribbin et al. 2011). Other studies found fallers were 2.88x, 2.80x and 1.29x more likely to 
be taking anti-depressants than non-fallers (Du et al. 2017; Masud et al. 2013; Spoelstra et al. 
2013), respectively. Three studies did not find that anti-depressants were predictive of falls 
(Cumming et al. 1991; Iinattiniemi et al. 2009; Landi et al. 2005).   
2.3.3.3 Anti-Depressants and Recurrent Falls 
In one study of 21,596 Australian community-dwelling older adults (aged >60 years), 
18.9% of those who had 1 falls in the past year were taking an anti-depressant (Kerse et al. 
2008). The use of anti-depressants was associated with recurrent falls in four studies. Two 
studies showed that taking anti-depressants resulted in a fall risk of 3.15x and 2.9x, respectively 
(Du et al. 2017; Masud et al. 2013). Females aged ≥65 years taking anti-depressants were 2.84x 
(Lord et al. 1995) and 1.54x (Ensrud et al. 2002) more likely to have recurrent falls compared to 
non-users, respectively.  
2.3.3.4 Anti-Depressants and Injurious Falls 
Anti-depressants were significantly associated with injurious falls (OR=1.46; 95% CI 
1.21-1.78) (Kelly et al. 2003). In females aged 80 years, those taking SSRI’s had a 3.96 greater 
risk of suffering an injurious fall compared to females taking other anti-depressants (e.g. 
tricyclics, MAIOs) (Kerse et al. 2008). Kerse and colleagues (2008) also examined TCAs, 
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MAIOs and ‘other’ anti-depressants on falls, but no significant differences between these 
medications and fall risk emerged.  
2.3.3.5 SSRI Anti-Depressant Use 
The use of SSRIs was examined in five studies (Du et al. 2017; Ensrud et al. 2002; 
Gribbin et al. 2011; Kerse et al. 2008; Masud et al. 2013). One study found that users of SSRIs 
had the highest risk of falls (OR= 6.22; 95% CI 2.28-17.9) compared to users of other anti-
depressants medications (i.e. synthetic anti-depressants (OR=2.66; 95%CI 1.50-4.73) and non-
selective mono-amino reuptake inhibitor anti-depressants (OR=1.84; 95%CI 0.83-4.10) (Du et al. 
2017). Similarly, another study reported that users of SSRIs were 1.55x more likely to have a 
single fall, 1.66x more likely to have recurrent falls, and 1.52x more likely to have injurious falls 
compared to those using other types of anti-depressants (Kerse et al. 2008). Females aged 65 
years and using SSRIs were 3.54x more likely to experience recurrent falls, however, TCAs were 
not significantly associated with recurrent falls (Ensrud et al. 2002). In a study of males, users of 
SSRIs were associated with single and recurrent falls (OR=3.1; 95% CI 2.0-5.0) and (OR=3.1; 
95% CI 1.8-5.6), respectively, as were TCA’s and falls (OR=2.2; 95% CI 1.0-4.7) (Masud et al. 
2013)  
The onset of medication use is also a risk factor of prospective falls. Within the first 28 
days of usage, SSRI’s resulted in a 2.04x, TCA usage a 1.61x and SNRI’s a 1.79x greater risk for 
prospective falls (Gribbin et al. 2011). There were two studies that included anti-depressants in 
their definition of CNS or sedative medications, however, no findings were reported specific to 
anti-depressant use and falls in their studies (Hanlon et al. 2009; Tinetti et al. 1988). 
  
 50 
2.3.4 Studies using Anti-Hypertensive Medications  
Twelve studies examined anti-hypertensive medication use and fall risk in older adults 
(Bergland et al. 2004; Blake et al. 1988; Cumming et al. 1991; Hanlon et al. 2002; Iinattiniemi et 
al. 2009; Kelly et al. 2003; Lord et al. 1993; Lord et al. 1995; Svensson et al. 1992; Tinetti et al. 
2014; Tromp et al. 1998; Wong et al. 2013). Sample sizes ranged from 307 (Bergland et al. 
2004) to 2,996 (Hanlon et al. 2002). The term falls was defined as “falling to the ground 
unintentionally” in six studies (Bergland et al. 2004; Cumming et al. 1991; Lord et al. 1993; 
Lord et al. 1995; Tromp et al. 1998; Wong et al. 2013) but not defined in the other six studies. In 
fallers, 13% to 85.9% were taking some form of anti-hypertensive medication. 
2.3.4.1 Anti-Hypertensives and Single and Recurrent Falls 
Seven studies found that anti-hypertensive medications were not associated with single or 
recurrent falls in males and females (Blake et al. 1988; Hanlon et al. 2002; Iinattiniemi et al. 
2009; Kelly et al. 2013; Lord et al. 1993; Lord et al. 1995; Svensson et al. 1992), four studies 
found a significant association (Bergland et al. 2001; Cumming et al. 1991; Tinetti et al. 2014; 
Tromp et al. 1998), and one found mixed results (Wong et al. 2013). Compared to non-users, 
users of anti-hypertensive medications had a 1.4x greater risk of falls and 1.6x greater risk of 
prospective falls (Tromp et al. 1998). Use of angiotensin-system blocking medication including 
ACEi and angiotensin receptor blockers was associated with fewer falls (Wong et al. 2013). In 
females, anti-hypertensives medication use increased injurious fall risk by 2.4x (Bergland et al. 
2004).  
2.3.4.2 Anti-Hypertensive Dosages 
One study found that diuretics and diltiazem were associated with recurrent falls in 
community dwelling older adults (Cumming et al. 1991). Higher doses of diltiazem (>180mg per 
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day) were also associated with a 10x greater risk of recurrent falls (Cumming et al. 1991). 
Moderate dosages, defined as (0.2-2.5 defined daily dose), increased injurious fall risk by 1.4x 
and 1.28x in high dosage users (defined as >2.5 defined daily dose) (Tinetti et al. 2014).  
2.3.5 Alcohol and fall risk 
2.3.5.1 Alcohol use and Older Adults 
Fourteen studies measured alcohol use via surveys (Anstey et al. 2008; Cumming et al. 
1991; Du et al. 2017; Hanlon et al. 2002; Hanlon et al. 2009; Kerse et al. 2008; Lord et al. 1993; 
Lord et al. 1995; Malmivaara et al. 1993; Masud et al. 2013; Stenbacka et al. 2002; Tinetti et al. 
1988; Tromp et al. 1998; Tromp et al. 2001) and one study measured alcohol concentration 
through blood samples (Kurzthaler et al. 2005). Alcohol use was defined as daily (Du et al. 2017; 
Hanlon et al. 2002; Lord et al. 1993; Lord et al. 1995), number of drinks per week (Anstey et al. 
2008; Kerse et al. 2008; Masud et al. 2013), alcohol intake per month (Anstey et al. 2008; 
Cumming et al. 1991), alcohol consumption as grams/per month (Malmivaara et al. 1993; 
Stenbacka et al. 2002), and as current, past or never drinker (Hanlon et al. 2009). Alcohol 
consumption was controlled for in three of the fourteen studies, however, quantity of alcohol was 
not described (Tinetti et al. 1988; Tromp et al. 1998; Tromp et al. 2001). Only one study defined 
high risk drinking; ≥7 drinks per week for females and ≥14 drinks per week for males (Kerse et 
al. 2008). Only three studies provided alcohol consumption rates which ranged from 18% to 70% 
(Anstey et al. 2008; Du et al. 2017; Hanlon et al. 2009; Kerse et al. 2008).  
2.3.5.2 Alcohol use and Falls 
Seven studies reported fall risk based on the number of drinks per day, week or month 
(Anstey et al. 2008; Cumming et al. 1991; Du et al. 2017; Kerse et al. 2008; Lord et al. 1993; 
Lord et al. 1995; Masud et al. 2013), one study reported alcohol use and falls based on ounces 
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per day (Hanlon et al. 2002), two studies reported alcohol use and falls based on grams 
consumed per month (Malmivaara et al. 1993; Stenbacka et al. 2002), and one study reported 
alcohol use and falls based on blood alcohol concentration levels (Kurzthaler et al. 2005).  
Alcohol consumption was significantly associated with falls in five studies (Anstey et al. 
2008; Kerse et al. 2008; Kurzthaler et al. 2005; Malmivaara et al. 1993; Stenbacka et al. 2002), 
but not in ten other studies (Cumming et al. 1991; Du et al. 2017; Hanlon et al. 2002; Hanlon et 
al. 2009; Lord et al. 1993; Lord et al. 1995; Masud et al. 2013; Tinetti et al. 1988; Tromp et al. 
1998; Tromp et al. 2001). Older adults who consumed less alcohol per month (<4 drinks) were 
more likely to fall compared to those who consumed more often (e.g. 2-3 times per week and 4 
times per week) (56.2% vs. 17.4% vs. 26.4%) (Anstey et al. 2008).  
Of the ten studies that found no association with falls, eight were cohort (Cumming et al. 
1991; Hanlon et al. 2002; Hanlon et al. 2009; Lord et al. 1993; Lord et al. 1995; Tinetti et al. 
1988; Tromp et al. 1988; Tromp et al. 2001) and two were cross-sectional (Du et al. 2017; 
Masud et al. 2013). Sample sizes ranged from 336 (Tinetti et al. 1988) to 4,696 (Masud et al. 
2013). Three studies measured alcohol based on the ounces consumed per day, number of drinks 
consumed on a drinking day and/or number of drinking days per week (Hanlon et al. 2002; Lord 
et al. 1993; Masud et al. 2013); however, seven studies did not report on the number of drinks 
consumed per day, week or month (Cumming et al. 1991; Du et al. 2017; Hanlon et al. 2009; 
Lord et al. 1995; Tinetti et al. 1988; Tromp et al. 1988; Tromp et al. 2001). Seven studies had a 
mixed sex composition (Cumming et al. 1991; Du et al. 2017; Hanlon et al. 2002; Hanlon et al. 
2009; Tinetti et al. 1988; Tromp et al. 1988; Tromp et al. 2001) while one study examined males 
only (Masud et al. 2013) and two examined females only (Lord et al. 1993; Lord et al. 1995).  
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2.3.5.3 Alcohol use and Injurious Falls 
Compared to younger adults, persons aged 51-70 years were more likely to be injured by 
a sudden fall after consuming alcohol (p<0.001) (Kurzthaler et al. 2005). Furthermore, 18% of 
males aged >70 years had consumed significantly more alcohol at the time of the fall compared 
to females (0.9%) (Kurzthaler et al. 2005). Males and females >64 years who heavily drank 
(≥1000 g/month for males, ≥500 g/month for females) were 8.45x and 14.63x more likely to 
have an injurious fall leading to hospitalization or death, respectively (Malmivaara et al. 1993). 
Similarly, females >60 years who consumed high levels of alcohol (≥500 g/month) were more 
likely to have an injurious fall compared to males (Stenbacka et al. 2002). 
2.3.6 Medications and Alcohol Together on Fall Risk 
One study examined the effects of CNS medications as a group (e.g. benzodiazepines, 
opioid receptor agents, anti-psychotics and anti-depressants) together with alcohol on fall risk 
(Hanlon et al. 2009). A two-way interaction between alcohol and CNS medications on recurrent 
fall risk was performed, however, the interaction was not significant (Hanlon et al. 2009).  
2.4 Discussion 
The findings from our review show that between 9% and 50.5% of community dwelling 
older adults reported a fall with 20% to 45.4% constituted as an injurious fall. Comparatively, 
more than 60% of older adults living in long-term care facilities fall each year (Rojas-Fernandez 
et al. 2015; Prudham et al. 1981; Tinetti et al. 1988; Campbell et al. 1989; Clark et al., 1993) 
with between 16.2% and 35% sustain an injurious fall once a year (Ek et al. 2017; Thapa et al. 
1996; Wang et al. 2001). Given that residents of long-term care are frailer than those living in 
community settings, it is not surprising fall rates are higher. However, it is surprising that 
injurious rates are comparable to that of community settings. Injurious falls in the community 
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may be more common due to external factors such as uneven sidewalks, uneven steps, icy roads, 
inappropriate use of equipment (e.g. climbing latters, use of heavy machinery), other pedestrians, 
cyclists or motor vehicles (Chippendale et al. 2015; Li et al. 2006).   
The majority of studies found that psychotropic medications including benzodiazepines, 
sedatives/hypnotics, anti-psychotics and anti-depressants were associated with falls in 
community dwelling older adults. Between 6.2% and 53.8% of benzodiazepine, sedative/ 
hypnotic or anti-psychotic users reported a fall. The sedating side effects of benzodiazepines may 
impair psychomotor function, cognitive function and increase daytime sleepiness, which can lead 
to falls (de Groot et al. 2013). Long-acting benzodiazepines have oxidative pathways that are 
more likely accumulate and stay in the body and are related to side effects such as prolonged 
sedation and cognitive impairment (Madhusoodanan and Bogunovic, 2004). This may partly 
explain why long-acting (>24 hours) compared to short-acting benzodiazepines (<24 hours) had 
higher fall rates. Diazepam is a long acting benzodiazepine and found to be predictive of falls in 
four studies (Cumming et al. 1991; Ensrud et al. 2002; Landi et al. 2005; Lord et al. 1995). Prior 
studies have hypothesized that diazepam may increase fall risk due its postural sway side effects 
(de Groot et al. 2013; Madhusoodanan et al. 2004).  
 Most studies found that anti-depressants had a significant association with falls in 
community dwelling older adults. This finding is consistent with prior reviews with mixed 
samples of older adults living in the community dwelling and long-term care (Leipzig et al. 
1999; Hartikainen et al. 2007; Park et al 2015; Woolcott et al. 2009). One particular anti-
depressant, SSRIs, had the greatest risk for falls compared to all other anti-depressant 
medications. SSRIs may result in a higher fall risk compared to other anti-depressant 
medications due to increased daytime sleepiness that often results from disrupted sleep cycles, 
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however, these side effects are not unique to SSRIs (Darowski et al. 2009; Diem et al. 2007). 
When examining other anti-depressant medications, TCA medications were also consistently 
associated with fall risk in two studies (Gribbin et al. 2011; Masud et al. 2013), which may be 
attributed to side effects such as sedation, daytime sleepiness and orthostatic hypotension 
(Darowski et al. 2009).  
Although the included studies found that between 13% and 85.9% were using anti-
hypertensive medication (Bergland et al. 2004; Blake et al. 1988; Cumming et al. 1991; Hanlon 
et al. 2002; Iinattiniemi et al. 2009; Kelly et al. 2003; Lord et al. 1993; Lord et al. 1995; 
Svensson et al. 1992; Tinetti et al. 2014; Tromp et al. 1998; Wong et al. 2013), most studies in 
this review found no association between anti-hypertensive medication and falls. Three studies 
did not report the number of older adults using anti-hypertensive medications (Hanlon et al. 
2002; Iianttiniemi et al. 2009; Lord et al. 1995). Additionally, eleven studies examined anti-
hypertensive medications as a broad category, and six studies examined individual anti-
hypertensive medications (Blake et al. 1998; Cumming et al. 1991; Hanlon et al. 2002; 
Iianttiniemi et al. 2009; Svennson et al. 1992; Wong et al. 2013). Only one study found an 
association between specific anti-hypertensive medication and falls. Diltiazen and diuretics were 
associated with recurrent falls (Cumming et al. 1991) whereas other studies did not find any 
association between falls and diuretics, as well as calcium channel blockers and beta-blockers.  
One study found that specific anti-hypertensive medications, angiotensin-receptor blockers 
(ACEi) and angiotensin system-blocking medications, were protective of fall risk in a small 
sample of community dwelling older adults compared to statins and psychotropic medications, 
however, the authors could not provide any reasons for this finding (Wong et al. 2013; Park et al. 
2015). Taken together, even though anti-hypertensive medications are commonly used in 
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community older adults, the evidence on fall risk is mixed and requires further investigation, 
particularly when examining individual anti-hypertensive medications.   
Fifteen studies examined alcohol consumption on fall risk with five studies finding an 
association. No studies produced rates of alcohol use. Differences in how alcohol consumption 
was measured made comparing studies challenging. For example, four studies measured daily 
alcohol consumption, three measured alcohol consumptions by week, and two measured alcohol 
by month. Furthermore, fourteen studies measured alcohol consumption was measured via 
surveys which is subject to recall and social desirability bias. Specific types of alcohol (i.e. 
spirits, wine, beer) were not specified in any study. While alcohol use typically declines with age 
(Britton et al. 2015; Wong et al. 2016), some studies suggest alcohol consumption increases with 
age (Han et al. 2017; Sorock et al. 2006). Future studies should consider measuring alcohol via 
blood samples to improve accuracy.    
 No studies found an association between alcohol and medications of interest together on 
fall risk. Concomitant alcohol and medication use at the time of the fall is nearly impossible to 
measure due to reporting bias, stigma and potential impaired memory. However, in western 
countries, concomitant alcohol and medication use ranges between 6% to 28% in older adults 
(Bye et al. 2017; Ilomaki et al. 2012; Ilomaki et al. 2013), suggesting it may be more common 
than previously assumed. Older adults represent the highest percentage of medication users. 
Polypharmacy is also associated with advanced age and falls (Chang et al. 2015; CIHI, 2012). 
Some research suggests as the population ages, alcohol use will become more common  (Han et 
al. 2017; Wong et al. 2016; Babatunde et al. 2014; Blow & Barry, 2012). Medications such as 
psychotropics and anti-depressants, as well as alcohol are identified as risk factors for falls 
(PHAC, 2014; WHO, 2007). Given that only one study examined medication use together with 
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alcohol, there is clearly a gap in research. Future studies should ask participants to report their 
frequency of alcohol consumption in combination with psychotropic, anti-depressant and anti-
hypertensive medication use.   
This review found there was substantial variation in study design, sample size, 
assessment of alcohol use, assessment of medication use, and falls. Differences in sampling 
techniques, sample size (<2000 vs. >300 000), sex, highest level of education achieved, income, 
diagnosed chronic illnesses, and cognitive function could explain why studies varied in results. 
While some studies were longitudinal studies, no two studies were identical in study design, 
sample size, independent variables, and statistical analysis, including controlling for confounding 
variables. The inconsistent terminology/definitions regarding medication classes made 
comparing studies challenging. For example, Haritkainen et al. (2007) defined psychotropics as 
hypnotics/sedatives, anxiolytics, anti-psychotics and anti-depressants; however, Bloch et al. 
(2011) defined psychotropics as benzodiazepines, anti-depressants, hypnotics, narcotics, 
neuroleptic tranquilizers, and psychotropics as a whole. In this review, Hanlon et al. (2009) 
categorized CNS medications as one whole group, but others separated medications by class and 
sub-class (Cumming et al. 1991; Gribbin et al. 2011; Du et al. 2017; Kerse et al. 2008; Lord et al. 
1995; Neutel et al. 1996). No study performed a randomized controlled trial. Future studies 
examining medications and fall risk should describe medications in detail (e.g. medication sub-
classes, the prescribed dosage and medication adherence) to warrant high quality analysis and 
replication. Future studies should classify medications according to the universal Anatomical 





 Anti-psychotic, benzodiazepines and anti-depressants, particularly SSRIs, were 
associated with increased fall risk in community dwelling older adults. Findings on anti-
hypertensive medications and alcohol consumption as a risk factor for falls are weak. Healthcare 
professionals should educate older adults on the potential risk for falls when taking these 
medications.  
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Chapter 3: Alcohol Use in Community Dwelling Older adults in Canada 
Overview  
Background and Objectives: Current Canadian alcohol consumption guidelines are developed 
for adults, however, their applicability to older adults is unknown. We seek to examine alcohol 
use in Canadian community dwelling older adults, determine risk factors associated with high-
risk drinking based on current guidelines, and determine whether the current low-risk drinking 
guidelines are applicable to older adults.   
Methods: Using data from the Canadian Injury Prevention Survey, we examined personal and 
health characteristics in community dwelling older adults (aged 65 and older) living in Canada as 
potential risk factors for high-risk alcohol drinking (N=2,279). Current Canadian alcohol 
consumption guidelines define high risk drinking as >10 drinks for females and >15 drinks for 
men, however, there is no moderate alcohol consumption category. We developed and examined 
new categories to determine if there was better differentiation between low, moderate and high-
risk alcohol use in older adults on various health and social outcomes. Descriptive statistics 
(mean, standard deviation and range) and comparative analysis (i.e. Chi-Square tests, 
independent t-tests and analysis of variance) were used compare alcohol consumption categories. 
Using logistic regression, we compared demographic and health factors to predict low and high-
risk drinkers using the current guidelines. Multinomial regression used demographic and health 
factors to predict low, moderate and high-risk drinking on health outcomes. 
Results: Participants age ranged between 65-96 years (Mean 72.8±5.9); 58% were females.  
70.1% of the sample reported having at least one drink on a weekly basis; 29.9% reported not 
consuming alcohol, 6.2% of men and 10.1% of women reported high-risk drinking. The 
regression models (Men: N=950, -2Log Likelihood Ratio=1452.0; Nagelkerke R2 = 0.09;  
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Women: N=1332, -2Log Likelihood Ratio=1818.1; Nagelkerke R2 = 0.08) showed having 
diabetes and being less likely to have daytime sleepiness were protective of high risk drinking in 
both males and females. The inclusion of the moderate alcohol consumption category showed no 
substantial differences in health and social outcomes in comparison to the current alcohol 
consumption guidelines.  
Conclusions: Canada’s current alcohol consumption guidelines appear to be suitable for older 



































The Canadian Tobacco, Alcohol and Drug Survey (CTADS) (2015) showed 66.2% of 
older adults consumed alcohol within the previous year (Health Canada, 2015; Health Canada, 
2017). The Canadian Community Health Survey (CCHS) (2016) also found that 10.5% of males 
and 4.3% of females ≥65 years reported drinking heavily (Statistics Canada, 2017). Drinking 
problems in older adults have the potential to become a large public health concern as hospital 
admission rates due to alcohol misuse are increasing (Sacco et al. 2015; Adams et al. 1993). For 
example, in older adults aged >65 years, alcohol related admissions have increased over seven 
years (b=0.88; t=8.84; p<.001) (Sacco et al. 2015). 
A study in the United States found that alcohol use increased by 40% between 2005-
2014, and females reported the largest increase by 84.6% (Han et al. 2017). The increasing use of 
alcohol may result in higher alcohol-related health problems (e.g. liver diseases, cardiovascular 
disease, poor oral health, decreased bone strength, increased risk of mortality) (Heuberger et al. 
2009) as the population lives longer. For example, deaths related to alcoholic liver disease in 
Canada increased by 15.9% from 2010 to 2014 (Statistics Canada, 2014). However, some 
research shows that alcohol may have a protective effect on certain health conditions. For 
instance, one study found that community dwelling females aged ≥70 years who consumed 1-2 
drinks per day over the week had better self-reported health (e.g. improved quality of life) and a 
greater survival rate compared to non-drinkers (Byles et al. 2006). 
Alcohol consumption guidelines for older adults may be necessary as they retain alcohol 
longer in the gastrointestinal track (e.g. stomach, liver, upper and small intestine) (Heuberger et 
al. 2009), are more likely to have mild cognitive impairment leading to poor decision making 
and judgement, suffer multiple comorbidities, practice polypharmacy, have a higher risk of 
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alcohol-drug interaction (Weathermon and Crabb, 1999), and are related to greater risk of motor 
vehicle accidents (Orces et al. 2013; Sorock et al. 2006), injuries and falls (Heuberger et al. 
2009; Kurzthaler et al. 2005; Stenbacka et al. 2006; WHO, 2009). Additionally, while drinking 
alcohol is often a social activity, excessive drinking can lead to financial strain, social isolation, 
and can worsen chronic health conditions (CDC, 2018; Heuberger, 2009; Statistics Canada, 
2016).  
The Canadian Centre for Substance Abuse (CCSA) provides alcohol consumption 
guidelines for the general population between the ages of 18 and 64 years to reduce the long-
term health effects of alcohol (e.g. some cancers such as liver, colorectal, laryngeal and oral, 
cirrhosis of the liver) and promote a culture of moderation and a healthy lifestyle (Health 
Canada, 2015). The current guidelines state females should not drink more than two drinks per 
day or ten drinks per week and that males should not drink more than three drinks per day or 15 
drinks per week. High risk drinking is defined as having >5 drinks for males and >4 drinks for 
females on one occasion at least once a month in the past year based on the World Health 
Organization and Health Canada guidelines for high risk drinking (Statistics Canada, 2016). 
High-risk drinking standards are used as an indicator for long-term health consequences (e.g. 
increased risk of cardiovascular disease) and risky behaviours (e.g. impaired driving, illicit drug 
use) (Statistics Canada, 2016). However, no alcohol consumption guidelines were created for 
older adults because of increased sensitivity to the effects of alcohol and medication use (Butt et 
al. 2011). Additionally, the current guidelines do not have a category for non-drinkers. In the 
current guidelines, non-drinkers are included in the low-risk category.  
In countries such as the United States, there are specific alcohol consumption guidelines 
for older adults. For example, the American Geriatrics Society and National Institute on Alcohol 
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Abuse and Alcoholism defines high risk drinking for older adults as having more than seven 
drinks per week or having three or more drinks on a given day based on clinical guidelines 
(National Institute on Alcohol Abuse and Alcoholism, n.d.). Italy is the only country to provide 
drinking guidelines to older adults in Europe, recommending that older adults do not consume 
more than one drink, or 12g of alcohol per day (Hallgren et al. 2010). In Singapore, it is 
recommended that males should not consume more than two drinks and females should not 
consume one drink per day, respectively (Ministry of Health Singapore, 2015).  
In the United States, alcohol consumption guidelines for older adults were developed by 
the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a national organization of 
scientists and experts in alcohol use (NIH, n.d). Alcohol consumption guidelines in Italy were 
developed based on collaboration with the Italian Ministry of Health, Italy’s National Health 
Institute, the Italian Society of Alcohology and indicators from the World Health Organization 
(Hallgren et al. 2009). Singapore’s guidelines are based on scientific evidence, although the 
source of the scientific evidence is not clear. Canada’s guidelines were developed by the 
National Alcohol Strategy Advisory Committee, consisting of independent Canadian and 
international experts (Butt et al. 2011; Canadian Centre on Substance Use and Addiction, 2011).   
Globally, there have been a limited number of studies examining alcohol consumption in 
older adults and few conducted in Canada. There has been no study to determine if the current 
alcohol guidelines are suitable for community dwelling older adults as they were not developed 
with older adults in mind. The primary objectives of this study are: 1) to examine alcohol 
consumption in Canadian community dwelling older adults using the present guidelines; 2) to 
develop and test a moderate alcohol consumption category on health and social outcomes; 3) to 
determine factors associated with high-risk drinking.  
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3.2 Methods 
3.2.1 Study population 
 
This population-based study recruited persons over the age of 45 from local, provincial 
and national organizations (e.g. Canadian Association of Retired Persons, Royal Canadian 
Legion) between July 2016 and June 2017. A list of all persons and organizations contacted can 
be found in Appendix B. Emails were sent to each organization consisting of a brief overview of 
the study, a letter of information, web-links to the surveys in both English and French and 
contact information for the Principal Investigator (Appendix C). The survey consisted of 89 
questions (Appendix D) and was completed using SurveyMonkey, an online survey 
management program. Prior to completing the survey, participants read a letter of information 
and provided informed consent. 
Any person aged 45 and older could complete the survey. In total, 4,614 participants 
completed the survey, however, the present study was restricted to persons 65 years of age, who 
were living in the community and completed the alcohol consumption module of the 
questionnaire. The final sample was 2,279. Persons were excluded from completing the survey if 
they were living in a long-term care facility or were using memory care services in a retirement 





Alcohol consumption was quantified as number of alcoholic drinks per week and number 
of drinking days per week. A dichotomous variable was created for alcohol use (yes or no) based 
on how participants answered the question “how many drinks do you have per week”. Canada’s 
alcohol consumption guidelines for persons aged 18-64 years define high risk drinking as 10 or 
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more drinks per week for females, and 15 or more drinks for men (Butt et al. 2011). Based on the 
distribution of the number of drinks participants reported to have consumed per week, we created 
drinking categories as follows for females: non-drinker (0), low (1-2), moderate (3-6), high (≥7); 
and non-drinker (0), low (1-2), moderate (3-9), high (≥10) for males. Categories were designed 
based on previous studies related to alcohol consumption in older adults (Immonen et al. 2011; 
Mukamal et al. 2004).   
Demographics 
Demographic variables included age, sex, living situation (alone, with a spouse or 
partner, with family members, with roommates unrelated), years retired, illness or disability 
before retirement, diagnosis of chronic illness, and self-perception of physical and mental health. 
Categorical variables were dichotomous (yes or no) or polytomous with more than two 
categories. Self-perceived physical and mental health scores were rated on a 10-point scale. 
Participants indicated whether they had a diagnosis of one or more of the following 
chronic health conditions. Health conditions included the following chronic conditions: arthritis, 
rheumatism, or osteoporosis; multiple sclerosis; Parkinson’s disease; stroke; dementia; high 
blood pressure, cholesterol, or heart problems; asthma or other breathing issues; diabetes; back 
problems; foot problems; hearing problems; cataracts, glaucoma, or macular degeneration; 
sleeping disorders; and depression.  
Behavioural Risk Factors 
Behavioural variables included smoking status, sleep quantity in 24 hours, and falls in 




Physical Activity  
Participants completed the short version of the International Physical Activity 
Questionnaire (IPAQ). The IPAQ is a valid tool for assessing physical activity in older adults 
(Chun, 2012; Tomioka et al. 2011). Scores were calculated using energy estimates (multiples of 
the resting metabolic rate or MET) assigned to each activity category (3.3 for walking, 4.0 for 
moderate, 8.0 for vigorous) x minutes of activity x days per week and produced a score for 
weighted MET minutes per week (www.ipaq.ki.se; Tomioka et al. 2011). Total MET scores are 
calculated by combining MET scores of walking, moderate physical activity, and vigorous 
activity (e.g. Total MET-min/week= (3.3 x minutes x days per week) + (4.0 x minutes x days per 
week) + (8.0 x minutes x days per week). Participants were scored as low, moderate and high 
physical activity levels (www.ipaq.ki.se, 2005).  
Sleep 
The potential for daytime sleepiness was assessed using the Epworth Sleepiness Scale 
(ESS). The ESS has eight questions that assesses daytime sleepiness in older adults who do not 
have serious cognitive impairment (Johns, 1991). Participants rated, on a 4-point scale (0-3), 
their likelihood of dozing off or falling asleep during an activity. Scores on the ESS range from 
0-24. Likelihood of daytime sleepiness is divided into categories based on score, normal (0-10), 
borderline (11-15), and abnormal (16-24) chance of falling asleep during the day. The ESS has 
shown good test-retest reliability, with high levels of internal consistency measured by 
Cronbach’s alpha (0.88) (Johns, 1991). We also asked participants to indicate the number of 




Cognitive function  
The Dysexecutive Questionnaire (DEX-S) is a reliable and valid measure for assessing 
executive function in older adults (Emmanouel et al., 2014; Shinagawa et al, 2007; Burgees et 
al., 1998). The DEX-S examines changes and difficulties in adults in the areas of emotion or 
personality, behaviour and cognition (Shaw et al. 2015; Gerstof et al. 2013). The 20-item 
questionnaire is scored on a 5-point scale from (0-4) with scores ranging from 0-80. During pilot 
testing of the survey, participants indicated that some questions on the DEX-S overlapped with 
other questions, prompting us to remove one of the items. Consequently, the current DEX-S 
includes 19 items; scores range from 0-76. Higher scores indicate more severe executive 
dysfunction (Shaw et al. 2015).  
3.2.3 Statistical analysis  
 
Data was coded and cleaned in Microsoft Excel before being transferred to SPSS 
(Version 24) for analysis. The following statistical analyses were performed for each objective:  
1) To examine alcohol consumption in Canadian community dwelling older adults using the 
present guidelines  
Descriptive information was presented using mean and standard deviation (Mean±SD) 
and range while categorical variables were presented using frequencies and percent. The Chi-
square test compared the association between categorical variables. If cell sizes were too small (n 
< 5), a Fisher’s exact test was used.  Independent t-tests compared the means of continuous 
health and social variables between low and high alcohol consumption categories. Statistical 




2) To develop and test a moderate alcohol consumption category on health and social outcomes  
Analysis of variance (ANOVA) compared personal and health characteristics  between 
low, moderate and high alcohol classifications.  
3) To determine predictors of high-risk alcohol drinking and compare current alcohol drinking 
consumption guidelines and a moderate alcohol consumption category  
Logistic regression identified risk factors for high-risk drinking using the current alcohol 
consumption guidelines. Multinomial regression identified risk factors for high-risk alcohol 
consumption. 
3.3 Results 
Table 3.1 illustrates the demographic and health related characteristics of our sample, 
separated by sex, using the current alcohol consumption guidelines.   
Males 
In males, the mean age was 72.7±5.9, and almost 80% lived with a spouse or partner. 
Sixty percent of males were retired for ≥10 years; self-perceived physical and mental health 
scores were 8.2±1.7 and 8.9±1.4, respectively. Only 3.6% of males were currently smoking. The 
most common medical conditions in males included high blood pressure, cholesterol or heart 
problems (60.3%), followed by arthritis, osteoporosis or rheumatism (38.5%). Overall, males 
reported usually sleeping 5.9±2.0 hours within 24 hours (day and night), and 90.6% reported a 
normal likelihood (4.6±3.0) of dozing off or falling asleep during the day. The mean score of the 
DEX-S questionnaire was 14.0±7.7, meaning the sample had a low likelihood of severe cognitive 





In females, the mean age was 72.8±5.9, and 51% lived with a spouse or partner. Nearly 
60% have been retired for ≥10 years; self-perceived physical and mental health scores were 
8.2±1.7 and 8.9±1.4, respectively. Only 3.1% of reported currently smoking. A diagnosis of 
arthritis, osteoporosis or rheumatism was reported by 59.7% of females, followed by high blood 
pressure, cholesterol or heart problems (49.4%). Similar to males, females also reported typically 
sleeping 5.9±2.0 hours within 24 hours (day and night), and 93.4% reported a normal likelihood 
(4.6±3.0) of daytime sleepiness. The mean score of the DEX-S questionnaire for females was 
14.0±7.7. Less than 1% of females were diagnosed with dementia.  
Alcohol use 
As shown in Table 3.1, alcohol was consumed by 70% of participants, consuming an 
average of 5.8±5.0 drinks per week, and drinking 3.7±2.2 days per week. Using the current 
alcohol consumption guidelines, 6.2% of males (>15 drinks per week) and 10.1% of females 
reported high-risk drinking (>10 drinks per week). Males classified as high-risk drinkers (>15 
drinks) consumed 21.6±3.5 drinks per week, and females classified as high-risk drinkers (>10 
drinks) consumed 15.1±3.8 drinks per week. Both males and females categorized as high-risk 
drinkers reported drinking 6.7±0.6 days per week. Males classified as high-risk drinkers were 
more likely to smoke compared to females who were high-risk drinkers. Females high-risk 
drinkers were significantly more likely to have, high blood pressure, cholesterol or heart 
problems, less likely to have diabetes, and sleep more hours in 24 hours compared to males 






Alcohol Use in Males 
 
 Males who smoked were more likely to be high-risk vs. low-risk drinkers (9.3% vs. 3.3), 
but differences were not significant. Compared to low-risk drinkers, high-risk drinkers were 
more likely to have higher self-perceived physical health and mental scores (8.41.5 and 
9.20.9), live with a spouse or partner (86%), and have high blood pressure, cholesterol or heart 
problems (69.2%) compared to low-risk drinkers, however, differences were not significant.  
 
Alcohol Use in Females 
 
 Females who smoked were more likely to be high-risk vs. low-risk drinkers (5.5% vs. 
2.9%), but differences were not significant. There were no significant differences between low 
and high-risk drinking and living situation. For example, 43.7% of females living alone were 
low-risk drinkers compared to 42.9% of females who were high-risk drinkers and lived alone. 
Similar to males, self-perceived physical and mental health scores were higher in high-risk 
drinkers. Females with asthma or other breathing problems were significantly more likely to be 
high-risk drinkers compared to low-risk (24.1% vs. 13.8%; p<0.05), as were females with high 
blood pressure, cholesterol or heart problems (60.8 vs. 48.6%; p<0.05).
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Table 3.1.  Descriptive statistics for males and females aged 65 and over for current Canadian Low-Risk Drinking Guidelines  














































































































































































































































































































































































































































































































































































































































































































































































































































Continuous variables are shown as means (SD); range and categorical variables as frequencies (%). Differences between groups were 
tested through Chi-Square or independent t-tests. 
The numbers reported in each cell represent the exact percentage of drinkers and non-drinkers for each of the exposures. Due to 
missing values, the denominator was not always 891 for low risk drinkers and 59 for high risk drinkers in males, and 1194 for low risk 
drinkers and 135 for high risk drinkers in females.  
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Table 3.2 illustrates descriptive statistics and comparative analyses for males which 
includes a new moderate category (3-9 drinks per week), and reduced limits for high-risk 
drinking (>10 drinks per week). Most males (32.8%) were categorized as moderate drinkers 
compared to none (25.3%), low (20.7%) and high-risk drinkers (21%). High-risk drinkers were 
more likely to live with a spouse or partner (85.4%), have higher rated self-rated physical health 
8.4±1.5, and be diagnosed with high blood pressure, cholesterol, or heart problems (59.1%). 
High-risk drinkers were significantly more likely to have higher self-rated mental health 
(9.2±1.1), normal likelihood of daytime sleepiness (4.7±2.9); and less likely to have an illness or 
disability prior to retirement and diabetes. The number of drinks was significantly positively 
correlated with physical (r=0.06; p<.01) and mental health (r=0.04; p>.05), however, age was 
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Continuous variables are shown as means (SD), range; and categorical variables as frequencies (%). Differences between groups were 
tested through Chi-Square or ANOVA. 
The numbers reported in each cell represent the exact percentage of low, moderate and high-risk drinkers for each of the exposures. 
Due to missing values, the denominator was not always representative of low, moderate and high-risk drinkers. 
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Table 3.2.1 demonstrates descriptive statistics and comparative analyses for females, 
with a moderate drinking category (3-6 drinks per week), and reduced limits for high-risk 
drinking (>7 drinks per week). In females, more reported non-drinking (33.1%) compared to 
22.1% who reported low-risk drinking, 23.3% who reported moderate drinking and 21% who 
reported high-risk alcohol drinking. High-risk drinkers were significantly more likely to live with 
a spouse or partner (59.9%), have high self-rated physical health 8.3±1.7, arthritis, osteoporosis 
or rheumatism (61.2%), sleep longer in a 24hr period (6.1±2.0) and have a normal likelihood of 
daytime sleepiness (3.9±2.7) compared to none, low and moderate drinkers. Similar to males, 
females high-risk drinkers were also less likely to have an illness or disability before retirement, 
and less likely to have diabetes, and there were no differences between smoking status and level 
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Continuous variables are shown as means (SD); range and categorical variables as frequencies (%). Differences between groups were 
tested through Chi-Square or ANOVA. 
The numbers reported in each cell represent the exact percentage of low, moderate and high-risk drinkers for each of the exposures. 
Due to missing values, the denominator was not always representative. 
Continuous variables are shown as means (SD); range and categorical variables as frequencies (%). Differences between groups were 
tested through Chi-Square or ANOVA. 
The numbers reported in each cell represent the exact percentage of low, moderate and high-risk drinkers for each of the exposures. 
Due to missing values, the denominator was not always representative of low, moderate and high-risk drinkers. 
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Tables 3.3 shows a comparison of the current alcohol consumption guidelines and the 
new alcohol consumption guidelines in males using logistic and multinomial regression. Having 
an illness or disability before retirement or diabetes, high self-rated physical and mental scores, 
and likelihood of daytime sleepiness were not predictive of the current low (<15 drinks per 
week) or high-risk (>15 drinks per week) drinking guidelines. There was a negative, but 
significant association with having an illness or disability before retirement, diagnosis of 
diabetes and likelihood of daytime sleepiness and high-risk drinking.  
 Table 3.4 is a comparison of the current alcohol consumption guidelines and the new 
alcohol consumption guidelines for females using logistic and multinomial regression. After 
adjusting for confounding variables, the current guidelines show that females whom have asthma 
or other breathing problems were 2.15x more likely to be high-risk drinkers (consuming >10 
drinks per week). There was a negative, but significant association between diabetes and 
moderate and high-risk drinking (p<0.01).   
In comparison, after controlling for the same variables, the new alcohol consumption 
guidelines show that having asthma or other breathing problems was not predictive of high-risk 
drinking (>7 drinks per week). Arthritis, osteoporosis or rheumatism was protective of low-risk 
drinking (1-2 drinks per week) (p<0.01), however, it was not protective of moderate (3-6 drinks 
per week) or high-risk drinking (p=0.96 and p=0.69), respectively. There was a negative, but 
significant association with moderate and high-risk drinking (p<0.001), as well as, a normal 
likelihood of daytime sleepiness. Self-rated physical health increased moderate drinking by 
1.21x (p<0.01), but was not associated with low or high-risk drinking. In turn, persons with 





Table 3.3 Comparison of current drinking guidelines and new alcohol consumption guidelines for males  














































































































Table 3.4 Comparison of current drinking guidelines and new alcohol consumption guidelines for females  
























































































































The present study found that 70% of community dwelling older adults reported drinking 
alcohol weekly; 74.6% of males and 66.8% of females. In our sample, 6.2% of males (defined as 
>15 drinks per week) and 10.1% of females were high-risk drinkers (defined as >10 drinks per 
week). Our prevalence rates are similar to findings of the Canadian Tobacco, Alcohol and Drug 
Survey (CTADS) that found 66.2% of community dwelling older adults consumed alcohol 
within the previous year (Health Canada, 2015; Health Canada, 2017). Population studies in 
other countries show that prevalence rates of alcohol use in community dwelling older adults are 
similar and range from 63% to 81% in Ireland (Cousins et al. 2014), Germany (Du et al. 2016) 
and Norway (Bye & Rossow, 2017).  
Other studies have also found that high risk drinking is more prevalent in males 
compared to females (Blazer and Wu, 2009; French et al. 2014; Immonen et al. 2011), however, 
definitions of high risk drinking were not consistent. With the inclusion of the moderate alcohol 
drinking category, we found 21% of males (>10 drinks per week) and 15% of females (>7 drinks 
per week) would be classified as high-risk drinkers. In males, asthma and other breathing 
problems was the only variable to predict high-risk drinking using the current alcohol 
consumption guidelines. No variables predicted high-risk drinking in men using the new alcohol 
consumption guidelines. In females, a diagnosis of asthma or other breathing problems was 
associated with high-risk drinking with the current alcohol consumption guidelines, and high 
self-rated physical health scores were predictive of moderate drinking. The majority of 
participants are within the current alcohol consumption drinking guidelines, suggesting the 
current guidelines may be adequate for community dwelling older adults. However, high-risk 
drinking is defined as consuming >15 drinks per week for males and >10 drinks per week for 
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females, which is a generous amount of alcohol for an older adult to consume per week. Active 
community dwelling older adults, such as the ones presented in this study may be aware that this 
amount of alcohol in a week is not healthy and choose to drink less.   
Physical activity and smoking were both not associated with high-risk drinking. There is 
a paucity of studies that have examined physical activity and alcohol consumption in older 
adults, however, one study found older adults who are more physically active consume more 
alcohol (Westerterp et al. 2004). Prior studies have found an association between low physical 
activity levels (low MET scores) with advanced age (Valim-Rogatto, 2011) and with females 
(Tomioka et al. 2011). Physical activity has also been linked to improved cognition (Bherer et al. 
2013; Olanrewaju et al. 2016; Weuve et al. 2004), sleep quality (Benloucif et al. 2004), and 
decreases fall risk (Suzuki et al. 2004) in community dwelling older adults. Overall, only 3.4% 
reported smoking which could explain why smoking was not a predictor of high-risk drinking. 
This finding was unexpected given that other large population studies in older adults have found 
that smoking is related to high-risk drinking in both males and females (Immonen et al. 2011; 
Merrick et al. 2008; Kirchner et al. 2007).    
In general, high-risk drinking can lead to a number of adverse events for older adults such 
as hypertension (Sesso et al. 2008), drug-alcohol interaction (Weathermon and Crabb, 1999) and 
injurious falls (Immonen et al. 2011; Stenbacka et al. 2002). High blood pressure, cholesterol and 
heart problems were associated with high-risk drinking in females but were not independently 
predictive in the logistic regression model. In this sample, almost half of females (49.4%) 
reported a diagnosis of high blood pressure, cholesterol or heart problems, with rates being 
significantly higher (53.3%) in older females (>80 and >85 years). However, in males, high 
blood pressure, cholesterol and other heart problems was not associated with high-risk alcohol 
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drinking. Our findings are similar to previous studies indicating that hypertension in females 
over the age of 60 is common (48.8%) and increases with advanced age (≥85 years) (63.3%) 
(Lionakis et al. 2012). Elevated blood pressure after menopause and increased body mass index 
may also contribute to why high blood pressure is more common in older females compared to 
men (Cifkova et al. 2008).  
3.5 Limitations 
Our study relied on self-reported data which is subject to recall and social desirability 
bias. Consistent with prior studies, it is likely that alcohol use may have been under-reported 
despite 70% of the sample stating they drink weekly (Livingston & Callinan, 2015; Stockwell et 
al. 2016). Additionally, our survey did not ask questions on marital status (divorced or single), 
income or education which are associated with drinking in older adults in prior studies (French et 
al. 2014; Merrick et al. 2008). Moreover, given the age of our sample, some individuals may 
suffer from memory loss although the majority of the sample performed adequately on the 
executive function test. Nevertheless, our results cannot be generalized to the broader population 
as our sample was generally healthy, belonged to community and advocacy organizations, and 
were familiar with computers. Additionally, given the large number or participants recruited 
from advocacy organizations, it is likely out sample was well educated with adequate financial 
means. Future studies should aim to include a more diverse population, and examine changes in 
alcohol use in community dwelling older adults over time.   
3.6 Conclusions  
 The majority of Canadian community dwelling older adults are within the recommended 
low-risk drinking guidelines. Our findings show that males consume more alcohol than females. 
The current alcohol consumption drinking guidelines in Canada appear to be adequate.  
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Chapter 4: Alcohol and Select Medications as Risk Factors for Falls in  




Background and Objectives: Older adults are frequently prescribed psychotropic medications 
and are consumers of alcohol, all of which are risk factors for falls. The objective of this study is 
to examine the associations between psychotropic medications (i.e. anti-psychotics, 
benzodiazepines), anti-depressants, and anti-hypertensives, both individually and concomitantly 
with alcohol on fall risk in community dwelling older adults.   
Methods: A sample of 2,281 community dwelling older adults aged ≥65 were analyzed from the 
Canadian Injury Prevention Survey. Data was collected on demographics, medication (e.g. 
psychotropics, anti-depressants, anti-hypertensives), alcohol use, and fall status. A univariate 
analysis was conducted to select variables for the regression models. Logistic regression models 
were fitted to determine predictors of falls. 
Results: The sample ranged in age from 65 to 96 years (Mean 73.1±6.2); 58% were woman. 
More than half of the sample were using anti-hypertensive medication (52%), 13.6% were using 
anti-depressants medication and 6.2 % psychotropic medication. Approximately 70% consumed 
alcohol on a weekly basis. One third of the sample reported falling in the previous two years 
(33.4%). Falls was significantly correlated with self-rated physical and mental health, 
comorbidity score, total psychotropic and anti-depressant medication use, and total number of 
medication use. Anti-hypertensive medication and alcohol use was not predictive of falls. 
Psychotropics as a group were predictive of falls, as were selective serotonin reuptake inhibitors, 
serotonin-norepinephrine reuptake inhibitors and serotonin antagonist reuptake inhibitors anti-
depressants.   
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Conclusions: Caution is needed when prescribing psychotropic and anti-depressant medications 














































Approximately 20-30% of all Canadian older adults fall each year (Public Health Agency 
of Canada, 2014) resulting in extended hospital stays, fractures (hip, wrist, and upper arm), 
immobilization, depression, loss of autonomy, morbidity, early admission to long-term care, and 
premature death (de Jong et al. 2013; PHAC, 2014; Todd et al. 2004; WHO, 2007). Fall risk is 
influenced by many factors including increased age, female sex, living alone, poor self-perceived 
health, development of chronic disease (e.g. arthritis, rheumatism or osteoporosis, cardiovascular 
disease, depression, sleep disorders), and polypharmacy (Brassington et al. 2000; Deandrea et al. 
2010; Kerse et al. 2008; Ocampo-Chaparro et al. 2013; PHAC, 2014). Medications such as 
psychotropic, anti-depressants and anti-hypertensives have been suggested as a fall risk factors 
for community dwelling older adults (Deandrea et al. 2010), as has alcohol (PHAC, 2014; WHO, 
2007), however, there is paucity of empirical evidence in community dwelling older adults.   
Between 81 to 88% of community dwelling older adults use at least one prescription 
medication (Rotermann et al. 2015; Qato et al. 2008; Scholes et al. 2013). Psychotropic 
medications such as anxiolytics, anti-psychotics, hypnotics/sedatives or anti-depressants and 
anti-hypertensives are among the most widely prescribed medications to older adults (Merel et 
al. 2017), used to treat anxiety, depression, insomnia and psychological distress (Lindsey, 2009). 
In 2012, approximately 15% of community dwelling older adults were prescribed a 
benzodiazepine, 4.4% an anti-psychotic, 19% an anti-depressant, and between 15 and 28% were 
prescribed a sub-class of anti-hypertensive medications (e.g. angiotensin converting enzyme 
inhibitor, beta-blocker, calcium channel blocker, angiotensin II antagonists or thiazide), meaning 
the overall rate of use is likely close to half the population of persons over 65 years (CIHI, 2012).  
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 Psychotropic medications are known to cause falls in older adults due to side effects 
such as psychomotor and cognitive deficits (e.g. confusion, muscle weakness, dizziness, loss of 
coordination) (de Groot et al. 2013; Madhusoodanan and Bugunovic, 2004). A recent study 
found that in community dwelling older adults, users of psychotropic medications were 1.57x 
times more likely to fall compared to non-fallers (Du et al. 2017). Furthermore, females using 
sedatives/ hypnotics were 1.5x more likely to have an injurious fall compared to males 
(Stenbacka et al. 2002). Psychotropic medications encompass as large group of sub-classes (e.g. 
hypnotics, sedatives, anti-psychotics, anxiolytics), however, little information exists on the 
effects of individual sub-classes on fall risk in community dwelling older adults.   
Anti-depressant medications, meanwhile, are used to treat depression. Sub-classes of 
anti-depressants include selective serotonin reuptake inhibitors (SSRIs), tricyclic anti-
depressants (TCAs), monoamine oxidase inhibitors (MAOIs), serotonin antagonist reuptake 
inhibitors (SARI), and serotonin-norepinephrine reuptake inhibitors (SNRI). Anti-depressant 
medications can cause side effects such as sedation, disrupted sleep, orthostatic hypotension 
impaired balance and coordination, all of which can increase the risk of falls (Darowski et al. 
2009; Milos et al. 2014). Several studies in community dwelling older adults have found an 
association between anti-depressant use and falls (Gribbin et al. 2011; Du et al. 2017; Kerse et al. 
2008; Marcum et al. 2016). Of all anti-depressant medications, SSRIs are the mostly widely 
prescribed and appear to have the greatest effect on falls, increasing fall risk by 1.55x for a single 
fall (Kerse et al. 2008) and 7.02x for recurrent falls compared to non-users (Du et al. 2017).  
Anti-hypertensives are used to treat high blood pressure. Sub-classes including diuretics, 
angiotensin converting enzyme inhibitor (ACEi), calcium channel blockers (CCB), beta-
blockers, and angiotensin II receptor antagonist (ARB). Findings on anti-hypertensive 
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medication use and falls are mixed (Cumming et al. 1991; Gribbin et al. 2010; Tinetti et al. 2014; 
Wong et al. 2013), which may be in part be to differences in terminology, study design and 
sample sizes (Wong et al. 2013). For example, Wong et al. (2013) found angiotensin-system 
blocking medications reduced fall risk in community dwelling older adults, however, the 
definition of angiotensin-system blocking medications included ACEi, CCB and ARB, that each 
come with its own set of side effects that can also elevate fall risk.   
Furthermore, the combined use of alcohol with either psychotropic, anti-depressants and 
anti-hypertensive use can result in increased sedation, psychomotor impairment, drowsiness, 
hypotension, disorientation, and falls (Moore et al. 2007; Weathermon and Crabb, 1999). While 
alcohol is a known risk factor for falls, few studies have examined alcohol and select medication 
use as a risk for falls in community dwelling older adults. Given the paucity of literature on the 
impact of psychotropic, anti-depressant and anti-hypertensive medications on fall risk, the 
primary aim of this study is to examine the association of psychotropic, anti-depressant, and anti-
hypertensive medications, both individually and together with alcohol on fall risk in community 




4.2.1 Study population 
 
 The survey consisted of 89 questions (Appendix B) and was completed using 
SurveyMonkey, an online survey management platform. This population-based study recruited 
participants aged 45 years and older from local, provincial and national organizations (e.g. 
Canadian Association of Retired Persons, Royal Canadian Legion) between July 2016 to June 
2017. Emails were sent to each organization consisting of a brief overview of the study, a letter 
of information, web-links to the surveys in both English and French, and contact information for 
the Principal Investigator (Appendix C). A list of all organizations contacted can be found in 
Appendix D. Prior to completing the survey, participants read a letter of information and 
provided informed consent. 
The survey was completed by 4,614 participants, however, the present study only 
examined fall risk in older adults. Participants were included if they were 65 years and older, 
community dwelling (e.g. living independently in a house, apartment, retirement home), and 
completed all questions on survey pertaining to alcohol and medication use, as well as falls. 
Participants were excluded if they were living in a long-term care facility, or a resident of a 
memory ward in a retirement home. The final sample size for the present study was 2,281. This 




Demographic variables included age, sex, living arrangements, employment status, 
illness or disability before retirement, years retired, and self-rated physical and mental health. 
Participants were asked to indicate if they had a diagnosis of one or more of the following health 
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conditions: arthritis, rheumatism, or osteoporosis; multiple sclerosis; Parkinson’s disease; stroke; 
dementia; high blood pressure, cholesterol, or heart problems; asthma or other breathing issues; 
diabetes; back problems; foot problems; hearing problems; cataracts, glaucoma, or macular 
degeneration; sleeping disorders; and depression. If participants had a health condition not listed 
on the survey, they were asked to indicate their diagnosis in the “other” category. Common 
‘other’ conditions included joint problems (shoulder, hip, knee), and leg cramps.  
Behavioural Risk Factors 
Behavioural variables included smoking status, alcohol use, prescribed medication use, 
physical activity, usual sleep quantity in 24 hours, and daytime sleepiness.  
Medication Use 
All participants self-reported their current prescribed medication. Subsequently, we 
classified participant medications according to the Anatomical Therapeutic Chemical (ATC) 
Classification System (WHO, 2007). Only medications listed as psychotropics (e.g. anti-
psychotics, anxiolytics, hypnotics/sedatives), anti-depressants including selective serotonin 
reuptake inhibitors (SSRI), serotonin antagonist reuptake inhibitors (SARI), serotonin-
norepinephrine reuptake inhibitors (SNRI), tricyclic anti-depressants (TCA), or other anti-
depressants; and anti-hypertensive medications including diuretics, beta-blockers, angiotensin 
converting enzyme inhibitors (ACEi), angiotensin II receptor antagonist (ARB), and calcium 
channel blockers (CCB) were examined. Medication use was classified as a binary variable 
(yes/no). A list of participants prescribed medications are shown in Appendix E. 
Alcohol  
Alcohol consumption was quantified as number of alcoholic drinks per week and number 
of days per week a person had a drink. Participants were asked “How many alcoholic drinks do 
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you consume per week”, “How many days per week do you drink”, and how many do you have 
per day”. A variable was created for alcohol use (yes or no) based on how participants answered, 
“how many drinks do you have per week”.  
Physical Activity  
Participants completed the short version of the International Physical Activity 
Questionnaire (IPAQ). The IPAQ is a valid tool for assessing physical activity in older adults 
(Chun, 2012; Tomioka et al. 2011). Scores are calculated using energy estimates (multiples of 
the resting metabolic rate or MET) assigned to each activity category (3.3 for walking, 4.0 for 
moderate, 8.0 for vigorous) x minutes of activity x days per week, producing a score for 
weighted MET minutes per week (www.ipaq.ki.se; Craig et al. 2003). Total MET scores are 
calculated by combining MET scores of walking, moderate physical activity, and vigorous 
activity (e.g. Total MET-min/week= (3.3 x minutes x days per week) + (4.0 x minutes x days per 
week) + (8.0 x minutes x days per week). Participants were classified as having a low, moderate 
or high physical activity level (IPAQ, 2005). Prior studies have associated low MET scores with 
advanced age, (Valim-Rogatto, 2011), female sex (Tomioka et al. 2011) and worse cognition 
(Bherer et al. 2013; Olanrewaju et al. 2016; Weuve et al. 2004) and poorer sleep quality 
(Benloucif et al. 2004) in community dwelling older adults. 
Sleep 
Sleep quantity was assessed using the Epworth Sleepiness Scale (ESS). The ESS has 8 
questions that assess daytime sleepiness in older adults (Johns, 1991). Participants are asked to 
rate on a 4-point scale (0-3) their likelihood of dozing off or falling asleep during an activity. 
Scores on the ESS range from 0-24. Likelihood of daytime sleepiness is divided into categories 
based on score, normal (0-10), borderline (11-15), and abnormal (16-24) chance of falling asleep 
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during the day.  The ESS has shown good test-retest reliability, with high levels of internal 
consistency measured by Cronbach’s alpha (0.88) (Johns, 1992). ESS scores >10 have shown to 
be independently associated with falling in the previous year among older females, but not males 
(Hayley et al. 2015). We also asked participants to indicate the number of hours they usually 
sleep in 24 hours. 
Cognitive function  
The Dysexecutive Questionnaire (DEX-S) is a reliable and valid measure for assessing 
executive function in older adults (Emmanouel et al., 2014; Shinagawa et al, 2007; Burgees et 
al., 1998). The DEX-S examines changes and difficulties in adults in the areas of emotion or 
personality, behaviour and cognition (Shaw et al. 2015; Gerstof et al. 2013). The 20-item 
questionnaire is scored on a 5-point scale from (0-4) with scores ranging from 0-80. Higher 
scores indicate poor executive functioning (Emmanouel et al. 2014; Shaw et al. 2015; Wilson et 
al. 1996). During pilot testing of the survey, participants indicated that some questions on the 
DEX-S overlapped with other questions, prompting us to remove one of the items. Consequently, 
the current DEX-S includes 19 items; scores range from 0-76.   
Falls 
Falls are the primary outcome variable and were assessed by asking participants “Have 
you fallen in the previous two years?”. Participants were classified as fallers and non-fallers.  
Fallers were defined as having one or more falls in the previous two years. If the participant had 





4.2.3 Statistical analysis  
Data was cleaned and coded in Microsoft Excel before being transferred to SPSS 
(Version 24) for analysis. Descriptive information was presented using mean and standard 
deviation and range while categorical variables were presented using frequencies and percent. 
Chi-Square tests for categorical variables and independent t-tests for continuous variables were 
performed to compare independent risk factors between fallers and non-fallers. Fischer’s exact 
test was used when expected frequencies had a sub-sample of less than 5 participants.  Pearson’s 
correlation was used to determine associations between continuous variables. Variables were 
selected for regression models based on univariate statistical significance. A logistic regression 
analysis was performed with each individual medication class adjusting for possible confounders 
(e.g. sex). Statistical significance was set as p<0.05.    
4.3 Results 
Characteristics of the study participants 
Table 4.1 represents the demographic and health related factors between fallers and non-
fallers. The mean age of the sample was 73.1±6.2 (range of 65 to 96 years); over half (58.2%) of 
the sample were females. More than 60% of the sample currently live with a spouse or partner 
(62.9%) and have been retired for >10 years (60.1%). Almost 30% reported using at least one 
prescription medication (29.3%) while 23.4% reported taking 5 or more medications. Alcohol 
use was reported by 70% of the sample drinking on average 4.1±4.9 drinks per week.  





























Females 1327 (58.2) 504 (66.1) 823 (54.2) 
Living situation 
Alone 
With a spouse or 
partner 
With family members 











































































































































Last eye exam 
Less than 2 years ago 
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Continuous variables are shown as Mean±SD and range; categorical variables as frequencies 
(%). Categorical variables between groups were examined using Chi-Square or Fisher’s exact 
test. The numbers reported in each cell represent the exact numbers of fallers and non-fallers for 
each of the exposures. Due to missing values, the denominator was not always 762 for fallers and 
1,519 for non-fallers.  
IPAQ: International Physical Activity Questionnaire 
 Fallers vs. Non-Fallers 
Approximately 33.4% of the sample reported falling in the past 2 years; 9% were 
hospitalized; and 11.2% experienced recurrent falls (2). The average age of those that fell were 
73.2±6.1 (range of 65 to 94 years). Compared to non-fallers, fallers were significantly more 
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likely to be older, a woman, to live with a partner or spouse, to have an illness or disability 
before retirement, to be physically and mentally tired, and poorer self-perceived physical and 
mental health scores. Fallers were also significantly more likely to have arthritis, rheumatism or 
osteoporosis, and have a diagnosis of two chronic health conditions. Fallers were also 
significantly more likely to use multiple medications compared to non-fallers (3.5±2.8 versus 
2.9±2.2). More females reported hospitalizations than males after a fall (55.9% vs. 44.1%), 
however, sex differences were not significant (p=0.44). Those who were hospitalized were 
slightly older than those who were not hospitalized (Mean 74±7.0 vs. Mean 72.9±5.9); age 
difference was not significant. Higher self-rated physical and mental health were protective of 
falls. 
Medication use 
Table 4.2 shows the associations of psychotropic, anti-depressant and anti-hypertensive 
medication use and respective sub-classes between fallers and non-fallers. Almost 30% reported 
using at least one prescription medication while 23.4% reported taking 5 or more medications. 
There were no significant sex differences in the number of medications being used. Psychotropic 
medications were used by 6.2% of the sample, anti-depressant medications were used by 13.5%; 
and 52% reported using an anti-hypertensive medication.  
Table 4.2. Associations of select medication use between fallers and non-fallers 








































































































































































































































































Continuous variables are shown as Mean±SD and range; categorical variables as frequencies 
(%). Categorical variables between groups were examined using Chi-Square or Fisher’s exact 
test. The numbers reported in each cell represent the exact numbers of fallers and non-fallers for 
each of the exposures. Due to missing values, the denominator was not always 762 for fallers and 
1,519 for non-fallers.  
 
Table 4.3 displays correlations among continuous variables. Age was not associated with 
number of falls but was with number of comorbidities and anti-hypertensive medication use, and 
negatively associated with self-perceived physical health and anti-depressant use. The number of 
falls were significantly and positively associated with comorbidity score, psychotropic and anti-
depressant medication use, while being significantly and negatively associated with self-rated 
physical and mental health score. Alcohol use was associated with anti-depressant use, 
specifically TCA medications, living with a spouse or partner and self-perceived physical health. 
Alcohol use was not associated with psychotropic and anti-hypertensive medication use and 







Table 4.3. Correlations of continuous variables and falls 




























Age  -0.03 0.02 -0.06** 0.02 0.07** -0.4 -0.12** 0.10** 0.04 
# of alcoholic 
drinks per 
week 
-0.03  -0.009 0.06** 0.04* -0.02 0.03 -0.02 0.01 -0.02 









0.02 0.04* -0.09** 0.50**  -0.18** -0.10** -0.18** 0.01 -0.11** 
Comorbidity 
score 














0.10** 0.01 0.02 -0.10** -0.10** 0.21** -0.06* 0.004  0.53** 
Total # of 
prescription 
medications 
0.04 -0.05* 0.15** -0.27** -0.11** 0.44** 0.18** 0.28** 0.53**  
Values are Pearson r; *p<.05 **p<.01
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Logistic regression models were performed with each medication class and sub-classes 
with falls (Table 4.4). Overall anti-depressants and specific individual classes (SSRIs, SARIs 
and SNRIs) were predictive of falls. When sex was entered into the model, all significant 
variables for Model 1 remained significant.  
Table 4.4 Logistic regression model showing individual medications as predictors of falls in 
older adults 
 Model 1 Model 2  
Use of any 
psychotropic 
1.51 (0.99-2.32) 1.43 (0.93-2.19) 
Anxiolytics 1.23 (0.64-2.34) 1.21 (0.63-2.32) 
Anti-psychotics 1.00 (0.29-3.44) 0.98 (0.28-3.42) 
Hypnotics/Sedatives 1.71 (0.95-3.07) 1.54 (0.86-2.78) 
Use of any anti-
depressants  
2.04 (1.51-2.76) 1.88 (1.38-2.55) 
Use of SSRI 2.07 (1.32-3.23) 1.89 (1.20-2.96) 
Use of SARI 4.27 (1.80-10.62) 4.23 (1.73-10.32) 
Use of SNRI 1.86 (1.08-3.20) 1.74 (1.01-2.99) 
Use of any anti-
hypertensive  
1.04 (0.84-1.28) 1.09 (0.88-1.35) 
Use of diuretics  1.00 (0.74-1.36) 0.99 (0.73-1.35) 
Use of beta-blockers 1.02 (0.75-1.40) 1.06 (0.77-1.46) 
Use of ACEi 1.05 (0.80-1.37) 1.13 (0.86-1.48) 
Use of ARBs 0.97 (0.74-1.29) 0.98 (0.74-1.30) 
Use of calcium 
channel blockers 
1.21 (0.90-1.62) 1.27 (0.94-1.72) 
Model 1: Medications individually predictive of fall risk 
Model 2: Adjusted for sex (female)  
SSRIs: Selective serotonin reuptake inhibitors 
SARIs: Selective antagonist and reuptake inhibitors 
SNRIs: Serotonin-norepinephrine reuptake inhibitor 




Thirty-three percent of the sample reported falls in the previous two years. Females 
reported falls more frequently than males (54.2% vs. 45.8%). Female sex and advanced age was 
associated with falls, consistent with other studies (Gale et al. 2016; Kerse et al. 2008; Stevens & 
Sogolow, 2005).  Unsurprisingly, a diagnosis of arthritis, rheumatism or osteoporosis, and vision 
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problem (e.g. cataracts, glaucoma and macular degeneration) was associated with falls. 
Furthermore, a diagnosis of two or more chronic health conditions (Gale et al. 2016), and use of 
multiple medications was also associated with falls, consistent with other studies (Hanlon et al. 
2009; Lord et al. 1993; Lord et al. 1995). Compared to males, females were significantly more 
likely to fall and have asthma or other breathing problems, and sleep disorders.  
Psychotropic medication use was not predictive of falls, which is surprising given that 
previous studies have found significant associations between psychotropic medications and falls 
in community dwelling older adults (de Rekeneire et al. 2003; Du et al. 2017; Lord et al. 1993; 
Lord et al. 1995; Wong et al. 2013). Over 6% of participants in this cohort used at least one 
psychotropic medication (e.g. anti-psychotic, anxiolytics, hypnotics/sedatives), and in fallers, 
7.8% used psychotropic medications. Hypnotics/sedatives were used by 4.3% of fallers, which is 
identical to prevalence rates in a cross-sectional survey of community dwelling older adults by 
Du and colleagues (2017). Sub-classes of psychotropic medications such as hypnotics, 
anxiolytics and anti-psychotics were not associated with falls in this study. In contrast, studies 
have found the aforementioned sub-classes are associated with falls in community dwelling older 
adults (Blake et al. 1988; Cumming et al. 1991; Ensrud et al. 2002; Hanlon et al. 2002; 
Iinattiniemi et al. 2009; Landi et al. 2005; Malmivaara et al. 1993; Masud et al. 2013; Neutel et 
al. 1996; Stenbacka et al. 2002; Tinetti et al. 1988; Tromp et al. 1998; Tromp et al. 2001). 
Dissimilarities in findings could be attributed to differences in sampling techniques, data 
collection (e.g. online vs. mail), medication terminology, sample size and characteristics of users 
vs. non-users.  
Use of anti-depressants, SSRI, SNRI and SARI medications were predictive of falls after 
controlling for sex. Anti-depressant medications were used by 13.5% of participants, and 10.4% 
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of fallers. All anti-depressants are known to disrupt sleep, cause insomnia, nocturia, and daytime 
sleepiness, potentially resulting in an elevated fall risk (Darowski et al. 2009). As a group, anti-
depressants were predictive of falls which has been found in other studies of community 
dwelling older adults (Blake et al. 1988; Du et al. 2017; Ensrud et al. 2002; Gribbin et al. 2011; 
Kelly et al. 2003; Kerse et al. 2008; Lord et al. 1995; Masud et al. 2013; Spoelstra et al. 2013; 
Svensson et al. 1992). When examining specific anti-depressants, SSRIs, SNRIs and SARIs were 
predictive of falls. SSRI medications were the most commonly prescribed sub-class of anti-
depressants in the sample (5.6%) and used more often in fallers (8.2%) compared to other sub-
classes. These rates are similar to prior studies of community dwelling older adults that show 
between 4.3% and 10.3% of SSRI users experienced a fall in the previous year (Du et al. 2017; 
Gribbin et al. 2011; Kerse et al. 2008). SNRI medications are newer anti-depressants, however, 
research on their association with fall risk is scarce. In the literature review (Chapter 2) only one 
study examined SNRI use and fall risk and found SNRI use predicted fall risk (Gribbin et al. 
2011). Seventy percent of SARI users in this cohort reported falls. This is consistent with studies 
in LTC that show depressed users of SARI medications were 20% were more likely to fall 
compared to non-users (Thapa et al. 1998). However, only a few studies suggest SARI 
medications elevate fall risk in older adults living in both community dwelling and LTC older 
adults. Regardless of our findings, a review on anti-depressant medications found no individual 
anti-depressant medications is associated of falls in community and LTC older adults (Darowski 
et al. 2009). 
More than 50% of the sample used anti-hypertensive medications, however, use of anti-
hypertensive medications as a group and sub-classes were not associated with falls in this cohort. 
The literature review (Chapter 2) found twelve studies that examined anti-hypertensive 
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medication use and fall risk in community dwelling older adults, four of which found an 
association with falls (Bergland et al. 2001; Cumming et al. 1991; Tinetti et al. 2014; Tromp et 
al. 1998). Angiotensin system-blocking medications which include diuretics, ACEis, ARBs and 
calcium channel blockers were associated with fewer falls in a sample of community dwelling 
older adults, however, the protective mechanisms are unclear.  
Although more than 70% of the sample reported drinking, there was no significant 
association with falls, consistent with previous studies (Du et al. 2017; Hanlon et al. 2009; Lord 
et al. 1993; Stuart et al. 2015; Tromp et al. 1998; Tromp et al. 2001; Williams et al. 2015). 
Females who consumed alcohol were more likely to report a fall compared to males (36% vs 
27.6%) but these differences were not significant. While it is impossible to know whether the fall 
was related to alcohol use, studies have shown alcohol use or abuse is a predictor of falls (Anstey 
et al. 2008; Kerse et al. 2008; Kurzthaler et al. 2005; Chang et al. 2015; Malmivaara et al. 1993; 
Stenbacka et al. 2002). However, due to the cross-sectional nature of this study we cannot 
determine causality inference between alcohol use and falls.  
4.5 Limitations 
There are several study limitations. The present study relied on survey data which is 
subject to recall and social desirability bias. However, our sample rated their physical and mental 
health as being above average, and few had cognitive limitations based on the DEX-S, 
suggesting that the sample was relatively healthy with little memory impairments. This is not 
surprising given our sample consisted of community dwelling older adults who were part of 
community-based senior organizations. Participants who are part of these organizations are 
generally more active, engaged, educated and more likely to be familiar with online surveys 
(computer technology). Moreover, we asked participations whether they had fallen in the past 
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two years. Unfortunately, we cannot determine directionality, whether medications resulted in 
falls or whether falls resulted in the use of medications. Furthermore, it is impossible to know if 
the participants were drinking and taking anti-depressants on the same day as the fall. However, 
we are following our participants longitudinally and will be able to determine causality in the 
future.  
4.6 Conclusion 
 The use of anti-depressant medications as a group, as well as individual anti-depressant 
medications (i.e. SSRI, SARI and SNRI) were predictive of falls in community dwelling older 
adults. Falls as are common in older adults, as are use of prescription medications. Consequences 
of falls are significantly more severe in older adults and healthcare providers should exercise 


















Chapter 5: General Discussion and Summary 
 
5.1 Introduction  
Falls are common in community dwelling older adults. The objectives of this thesis were 
to: i) synthesize peer-reviewed studies that have examined anti-psychotic, hypnotic/sedatives and 
benzodiazepines, anti-depressant and anti-hypertensive medications, both singly and in 
combination with alcohol as a risk for falls in community dwelling older adults;  ii) examine 
alcohol us in community dwelling older adults in Canada using current drinking guidelines, 
develop and test new alcohol consumption guidelines to better differentiate drinking habits on 
health outcomes, determine risk factors of high-risk drinking, and compare current drinking 
guidelines to moderate drinking; and iii) examine the effects of select medications, both 
individually and in combination with alcohol, on fall risk in Canadian community dwelling older 
adults.  
This chapter begins by discussing the findings of the literature review on select 
medications and alcohol on fall risk. Chapter 3 and 4 are original research articles and the first 
studies to use data from the Canadian Injury Prevention Survey. Conclusions and limitations are 
discussed, followed by a final section presenting implications for future research and practice.  
5.2 General Discussion 
Chapter 2 provides a foundation for the thesis by reviewing primary studies on anti-
psychotic, hypnotics/sedatives and benzodiazepines, anti-depressant and anti-hypertensive 
medications, as well as alcohol as a risk for falls in community dwelling older adults. A literature 
search using four electronic health databases, and a grey literature search yielded 1,146 articles 
for screening. Twenty-nine articles met the inclusion criteria. Overall females were more likely 
to be users of anti-psychotic, hypnotics/sedative, benzodiazepines and anti-depressant 
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medications compared to males. Females were also more likely to fall, which has been found in 
other studies (Chang et al. 2015).  
Up to 58.7% of anti-psychotic, hypnotics/sedative and benzodiazepines users reported a 
fall. Users of anti-depressant medications, specifically SSRI medications had the highest risk of 
falls compared to other sub-classes of anti-depressants (Du et al. 2017; Ensrud et al. 2002; Kerse 
et al. 2008; Masud et al. 2013). Overall, anti-hypertensive medication use was not associated 
with increased fall risk in community dwelling older adults. Compared to younger and middle-
aged adults, older adults consumed alcohol less frequently; however, they were also more likely 
to have an injurious fall after consuming alcohol (Kurzthaler et al. 2005; Malmivaara et al. 1993; 
Stenbacka et al. 2002). Alcohol and select medication use was not associated with falls in 
community dwelling older adults.  
Chapter 3 explored alcohol use in community dwelling older adults in Canada. We 
sought to determine risk factors associated with high-risk drinking based on the current alcohol 
consumption guidelines; and determine whether the current guidelines are applicable to older 
adults. Seventy percent of Canadian older adults reported drinking. Findings suggest the current 
alcohol drinking guidelines for adults aged 18-64 may be adequate for community dwelling older 
adults.  
Chapter 4 examined the role of alcohol and its interaction with various medications (i.e., 
psychotropic, anti-depressants, and anti-hypertensives) on fall risk in Canadian older adults. 
Females reported falls more frequently compared to males. Diagnosis of arthritis, osteoporosis, 
or rheumatism, cataracts, glaucoma or macular degeneration, asthma or other breathing problems 
and foot problems were directly significantly associated with falls. Strong self-rated physical and 
mental health were protective of falls. Alcohol use was not associated with falls. Logistic 
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regressions indicated that the use of anti-depressants as a group, SSRI, SNRI and SARI anti-
depressants were predictive of falls.  
 Overall, participants were healthy. This is the first set of results from the Canadian Injury 
Prevention Survey, and to our knowledge, the first study to examine alcohol and select 
medication use as a risk for falls in older adults in Canada. Polypharmacy is a growing public 
health concern. Within our sample, 23.4% reported taking 5 or more medications on a daily 
basis. Alcohol drinking is common in older adults and evidence suggests that high-risk episodic 
drinking is not uncommon among older males (St John et al. 2010). Furthermore, there is 
concern that as the baby boomers begin to age, the prevalence of high-risk drinking will increase 
(Han et al. 2017; Wong et al. 2016; Babatunde et al. 2014; Blow & Barry, 2012). While fall risk 
is multifactorial, alcohol and medication use are recognized as fall risk factors by the WHO 
(WHO, 2007). Falls are preventable and healthcare professionals should educate older patients 
and caregivers of the negative consequences. 
5.3 Implications  
5.3.1 Research 
To date, few studies have examined concomitant alcohol and psychotropic and anti-
depressant medication in community dwelling older adults (Bye et al. 2017; Ilomaki et al. 2012; 
Ilomaki et al. 2013). No studies have examined concomitant alcohol and select medication use as 
a risk for falls in community dwelling older adults. Future studies are needed in this area to 
confirm if concomitant alcohol and medication use is a risk factor for falls in older adults. 
Findings of this thesis indicate research on the use of anti-hypertensive medications as a risk for 
falls is scarce. Future research is required to explore the associations between anti-hypertensive 
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medication use, both overall as a class and individual medications and falls in community 
dwelling older adults.  
5.3.2 Practice  
 
Clinicians should be transparent with their patients and identify the risks of using 
psychotropic, anti-depressant and anti-hypertensive medications. Each medication class is known 
to be accompanied by side effects such as poor balance, sedation and sleep disturbance (de Groot 
et al. 2013; Madhusoodanan and Bugunovic, 2004; Milos et al. 2014). Physicians should discuss 
alcohol use and the potential adverse reactions with medications, including falls and injurious 
falls (Immonen et al. 2013; Stenbacka et al. 2002) with older patients. Furthermore, alcohol 
should be consumed in moderation to prevent worsening of chronic illnesses.  
5.4 Limitations  
 
 This thesis is not without limitations including. The limitations and future directions are 
discussed below. 
5.4.1 Study Design 
The primary limitation of this thesis is the cross-sectional study design. Cross-sectional 
studies are inadequate at measuring causation and determining risk. The survey consists of 89 
questions in length, taking approximately 45 minutes to complete and many responses were 
incomplete at the end. The Canadian Association for Retired Persons (CARP) e-mail blasted 
over 300,000 members at once and as a result we encountered many technical difficulties 
including server failure. Although these issues were resolved with the assistance of 
SurveyMonkey technicians, we received many complaints from respondents. We also learned 
that SurveyMonkey is not very compatible with iPads or smart phones, decreasing our response 
rate. The survey was available in print and online in English and French, however, no persons 
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used a print version, and the French response rate was very low (n=<40). All data was collected 
online, potentially eliminating older adults (≥85) who do not have e-mail, or a computer. Lastly, 
this was the first wave of participants to complete this survey and we found a few questions were 
subject to misinterpretation even after pilot work.  
5.4.2 Sample 
 Our sample consisted of community dwelling older adults living in Canada and the 
primary source of recruitment was from CARP, Probus Clubs, and the Canadian Association of 
Retired Teachers. Members of these organizations are typically more engaged and active in the 
community. Furthermore, to be a member there is usually an annual fee, therefore, our sample 
likely consists of persons in high income brackets whom have achieved high levels of education. 
However, we cannot be sure of the socioeconomic status or education level of our participants 
because in consultation with researchers from Bordeaux, questions about income and education 
were eliminated as they did not serve importance in previous Gazel cohort studies.  
5.5 Conclusions 
  In summary, the literature review findings confirmed that psychotropic and anti-
depressant use are predictive of falls in community dwelling older adults. However, based on the 
survey with community dwelling older adults, only anti-depressant drug use was found to be 
significantly associated with fall risk.  Anti-hypertensive medications were not  associated with 
falls, nor was alcohol. Physicians should exercise a high degree of caution when prescribing 
psychotropic and anti-depressant medications to older adults whom may be at a high fall risk.
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